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ABSTRACT 
Sara Lynn Rohrabaugh 
 
EFFECTS OF ALTERING CELL PROLIFERATION ON HEMATOPOIETIC 
STEM AND PROGENITOR CELL FUNCTION 
 
Cell cycle checkpoints guarantee movement through the cell cycle in an 
appropriate manner.  The spindle assembly checkpoint (SAC) ensures the proper 
segregation of chromosomes into daughter cells during mitosis.  Mitotic arrest 
deficiency 2 (Mad2), a member of the mitotic checkpoint proteins, appears to be 
crucial for generating the wait anaphase signal to prevent onset of anaphase.  
We first studied the SAC in hematopoietic stem cells (HSC) to ensure that it was 
functional.  Our previous studies found that prolonged SAC activation was 
uncoupled from apoptosis initiation in mouse and human embryonic stem cells 
(ESC).  We found that upon treatment with a microtubule-destabilizing agent, 
HSC arrested in M-phase and subsequently initiated apoptosis.  Thus unlike 
ESC, HSC exhibit coupling of prolonged SAC activation with apoptosis.  We 
studied the effects of Mad2+/- on in vivo recovery of bone marrow HPC from 
cytotoxic effects and also effects of cytostatic agents on HPC growth in vitro 
using Mad2-haploinsufficient (Mad2+/-) mice.  We found that Mad2+/- HPCs were 
protected from the cytotoxic effects of cytarabine (Ara-C), a cycle specific agent, 
consistent with Mad2+/- HPCs being in a slow or non-cycling state.  Mad2 
haploinsufficiency did not affect recovery of functional HPC after treatment with 
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cyclophosphamide or high sub-lethal dose irradiation, both non-cycle specific 
agents.  There were no differences in immunophenotype defined HSCs in 
Mad2+/- and Mad2+/+ mice, data confirmed by functional HSC competitive 
repopulation assays.  To better understand the role of Mad2 in HPC, E3330, a 
cytostatic agent, was used to assess the redox function of Ape1/Ref-1, and 
colony formation in vitro was examined under normoxic and lowered O2 tension.  
Mad2+/- HPCs were less responsive to E3330 than Mad2+/+ HPCs, and E3330 
was more effective under lowered O2 tension.  Mad2+/- HPCs did not exhibit 
enhanced growth in lowered oxygen tension, in contrast to Mad2+/+ HPCs.  Our 
studies have unexpectedly found that Mad2 haploinsufficiency is protective from 
the cytotoxic effects of a cycle specific DNA synthesis agent in vivo, and 
Ape1/Ref-1 inhibitor in vitro. 
 
Hal E. Broxmeyer Ph.D., Chair 
  viii 
TABLE OF CONTENTS 
 
LIST OF TABLES ................................................................................................... xi 
LIST OF FIGURES ................................................................................................. xii 
LIST OF ABBREVIATIONS.................................................................................... xiv 
INTRODUCTION..................................................................................................... 1 
Mitosis and the Spindle Assembly Checkpoint ....................................................... 1 
Recognizing the Lack of Occupancy at the Kinetochore......................................... 9 
Regulation of Kinetochore-Microtubule Attachments in Lack of Tension................ 13 
The Importance of Mad2 in the SAC....................................................................... 20 
Examining the Role of the SAC and Mad2 in Hematopoiesis ................................. 22 
Investigation of the Role Ape1/Ref-1 Plays in Hematopoiesis ................................ 25 
Research Goals ...................................................................................................... 29 
MATERIALS AND METHODS ............................................................................... 33 
Mice......................................................................................................................... 33 
Cytokines, Antibodies, and Other Agents ............................................................... 33 
Histological Analysis ............................................................................................... 34 
Isolation and Culture of LDMCs From Murine BM .................................................. 35 
Multivariate Permeablized Flow Cytometry............................................................. 35 
Phenotypic Analysis ................................................................................................ 36 
Clonogenic Progenitor Cell Assay........................................................................... 37 
Recovery of BM Progenitors From Cytotoxic Effects .............................................. 38 
Competitive Repopulation Assay ............................................................................ 38 
  ix 
Secondary Non-competitive Transplantation .......................................................... 39 
Statistical Analysis .................................................................................................. 39 
RESULTS ............................................................................................................... 40 
Nocodazole Treatment Causes Cell Cycle Arrest in HSCs..................................... 40 
Phenotypically Defined HSCs Initiate Apoptosis After SAC Activation ................... 43 
SAC Activation Results in Mitotic Arrest and Apoptosis in Phenotypically  
Defined HSCs From Both Mad2+/+ and Mad2+/- Mice .............................................. 46 
Aged Mad2+/- Mice Exhibit Characteristics of a Myeloproliferative-like  
Disorder................................................................................................................... 49 
Mad2 Haploinsufficiency Protects HPC From the Cytotoxic Effect of 
Cell-Cycle Specific Chemotherapeutic Agents........................................................ 56 
Decreases in Progenitor Numbers and Cycling Status are Observed in BM 
HPC From Mad2+/- Mice.......................................................................................... 64 
Phenotypic Characterization of HSC and HPC Population in Mad2+/- and  
Mad2+/+ Mice ........................................................................................................... 67 
Mad2 Haploinsufficiency Does Not Affect the Long-Term  
Repopulating Ability of HSC Compared to Wild-type Mad2+/+ HSC........................ 71 
Mad2+/- BM HPC are Less Sensitive to the Cytostatic Effects Caused by  
Blocking the Redox Function of Ape1/Ref-1 and Do Not Respond Well 
to the Effects of Lowered O2 Tension...................................................................... 76 
  x 
DISCUSSION .......................................................................................................... 83 
FUTURE DIRECTIONS .......................................................................................... 96 
REFERENCES........................................................................................................ 101 
CURRICULUM VITAE 
  xi 
LIST OF TABLES 
 
INTRODUCTION 
Table 1. Components of the Spindle Assembly Checkpoint.      7 
RESULTS 
Table 2. Observations in Aged Mad2+/- and Mad2+/+ Mice.      54 
 
  xii 
LIST OF FIGURES 
 
INTRODUCTION 
Figure 1. Summary of the SAC Signaling in Mitosis.   3 
Figure 2. Models of APC Inhibition Through Binding of the  
Mitotic Checkpoint Complex (MCC) in Response to 
Unattached Kinetochores.      11 
Figure 3. The Chromosomal Passenger Complex (CPC)  
Corrects Incorrect Microtubule Attachments and  
Indirectly Activates the SAC.     18 
Figure 4. The Hierarchy of Hematopoietic Cells.    23 
RESULTS 
Figure 5. HSCs Arrest in M-phase After Nocodazole Treatment.  41 
Figure 6. After Arresting in M-phase, HSCs Initiate Apoptosis.  44 
Figure 7. Mad2+/+ and Mad2+/- HSCs Arrest in M-phase After  
Nocodazole Treatment.        47 
Figure 8. Aged Mad2+/- Mice Exhibit Characteristics of a  
Myeloproliferative Disorder.     51 
Figure 9. No Difference in the Recovery of Mad2+/+ and Mad2+/-  
BM and Spl HPC After Cyclophosphamide Treatment.  58 
Figure 10. No Difference in the Recovery of Mad2+/+ and Mad2+/-  
BM and Spl HPC After Treatment with γ-Irradiation.   60 
  xiii 
 
Figure 11. Mad2+/- BM Cells, Unlike Mad2+/+ BM Cells, are  
Protected From the Cytotoxic Effects of Ara-C.   62 
Figure 12.   Functional Analysis of BM HPC Demonstrates  
Decreased Numbers and Cycling of Mad2+/- HPC.  65 
Figure 13. Phenotypic Analysis of HSC and HPC Populations  
Reveals No Changes in LSK, CLP, GMP, and MEP,  
But a Slight Increase in CMPs in Mad2+/- Mice.   68 
Figure 14. Mad2 Haploinsufficiency Does Not Affect the  
Long-Term Repopulating Ability of HSC Compared to  
Wild-Type HSC       73 
Figure 15. Mad2+/- BM Cells are Less Sensitive to the Cytostatic  
Effects Caused by Blocking the Redox Function of  
Ape1/Ref-1 Compared to Mad2+/+ BM Cells.    78 
  xiv 
LIST OF ABBREVIATIONS 
 
5-FU   5-Fluorouracil 
Ala   Alanine 
AP-1   Activator protein-1 
APC   Allophycocyanin 
Ape1/Ref-1  Apurinic/apyrimidinic endonuclease/redox factor-1 
Ara-C   Cytarabine 
BER   Base excision repair 
BFU-E  Burst forming unit-erythroid 
BIR   Baculovirus IAP repeat  
BM   Bone marrow 
BSA   Bovine serum albumin 
CENP-E  Centromere protein-E 
CD34   Cluster of differentiation molecule 34 
Cdc   Cell division cycle 
CDK   Cyclin dependent kinase 
CFU-GEMM Colony forming unit-granulocyte, erythroid, macrophage, 
megakaryocyte 
CFU-GM  Colony forming unit-granulocyte-macrophage 
CIN   Chromosomal instability 
c-kit   SCF receptor 
CLP   Common lymphoid progenitor 
  xv 
CMP   Common myeloid progenitor 
CPC   Chromosomal passenger complex 
CRA   Competitive repopulation assay 
Cys   Cysteine 
DAM   Duo1- and Mps1 interacting complex 
DMSO  Dimethyl sulfoxide 
DNA   Deoxyribonucleic acid 
EB   Embryoid body 
Egr-1   Early growth response protein-1 
EPO   Erythropoietin 
ESC   Embryonic stem cell  
FACS   Fluorescence activated cell sorting 
FBS   Fetal bovine serum 
FcγR   Fc (fragment crystallization) gamma receptor 
Flt3   FMS-like tyrosine kinase 3 ligand 
GMP   Granulocyte/macrophage progenitor 
GM-CSF  Granulocyte/macrophage colony stimulating factor 
H&E   Hematoxylin and eosin stain 
HEC-1  Highly expressed in cancer-1 
HIF-1α  Hypoxia inducible factor-1α 
HPC   Hematopoietic progenitor cell 
HSC   Hematopoietic stem cell 
IAP   Inhibitor of apoptosis protein 
  xvi 
 
IMDM   Iscove’s modified Dulbecco’s medium 
INCENP  Inner centromere protein 
i.p.   Intraperitoneal 
i.v.   Intravenous 
KL   C-kit+, Lin- 
KMN complex KNL-1, Mis12 complex, and Ndc80/HEC1 
KNL-1   Kinetochore NuL-1 
LDMC   Low-density mononuclear cells 
Lin   Lineage 
LSK   Lin-, Sca-1+, c-kit+ 
Mad2   Mitotic arrest deficiency 2 
MCC   Mitotic checkpoint complex 
MCK   Mitotic centromere-associated kinesin 
MDR   Multi-drug resistance 
MEN   Mitotic exit network 
MEP   Megakaryocyte/erythroid progenitor 
MPD   Myeloproliferative disorder 
Mps1   Monopolar spindle 1 
NAC   N-acetyl-L-cysteine 
NF-κB   Nuclear factor-κB 
O2   Oxygen 
PARP   Poly (ADP-ribose) polymerase 
  xvii 
PB   Peripheral blood 
PBS   Phosphate buffered saline 
PE   Phycoerythrin 
PWMSCM  Pokeweed mitogen spleen conditioned media 
RBC   Red blood cell 
rhu   Recombinant human 
rmu   Recombinant mouse 
ROS   Reactive oxygen species 
RPMI   Roswell Park Memorial Institute medium 
SAC   Spindle assembly checkpoint 
s.c.   Subcutaneous 
Sca-1   Stem cell antigen-1/Ly-6A/E 
Scc   Sister chromatid cohesin 
SCF   Stem cell factor 
SDF-1α  Stromal-cell derived factor 1 alpha 
SL    Sca-1+, lin - 
SMC   Structural maintenance of chromosome 
Spl   Spleen 
Thr   Threonine 
TLK-1   Tousled-like kinase-1 
TPO   Thrombopoietin 
 
  1 
INTRODUCTION 
 
Mitosis and the Spindle Assembly Checkpoint. 
During S-phase of the cell cycle, a single round of DNA replication results in two 
identical DNA copies known as sister chromatids.  This is followed by G2 phase, 
in which the cells grows and prepares for M (mitotic) phase, which results in 
chromosome segregation and ultimately the generation of two daughter cells.  In 
order for chromosomes to be evenly distributed into the daughter cells, sister 
chromatids need to be held together until the appropriate time with cohesin.  
Cohesin is a highly conserved protein complex comprised of four subunits, 
structural maintenance of chromosomes SMC1 and SMC3, and sister chromatid 
cohesins (Scc) Scc3 and Scc1 (Nasmyth 2001).  Sister chromatids attach to 
spindle microtubules via kinetochores, which assemble at the centromere on 
each of the sister chromatids of a chromosome (Cleveland, et al. 2003; Hauf and 
Watanabe 2004; Mazia 1961).  Cohesin is essential for sister chromatids to 
become attached to opposing poles of the mitotic spindle, a configuration known 
as amphitelic attachment, and a pre-requisite for accurate segregation of the 
genome (Homer 2006).   
 
After all sister chromatids have become amphitelically attached in metaphase, 
the cell can then initiate anaphase, the stage of mitosis when chromosomes 
separate; this requires that cohesin along both chromosome arms and 
centromeres be resolved (Figure 1) (Homer 2006).  In vertebrates, the majority of 
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arm cohesins are removed during prometaphase by a cleavage-independent 
mechanism mediated by polo-like kinase and Aurora-B kinase (Gimenez-Abian, 
et al. 2004; Losada, et al. 2002; Sumara, et al. 2002).  Complete resolution of 
cohesin and anaphase onset is ultimately dependent upon cleavage of the Scc1 
subunit of the cohesin complex by a thiol protease known as separase (Hauf, et 
al. 2001; Waizenegger, et al. 2000).  The activity of separase is negatively 
regulated by its association with securin, an inhibitory chaperone, and by 
phosphorylation induced by cyclin-dependent kinase 1 (Cdk1) (Stemmann, et al. 
2001).  The destruction of securin and cyclin B, the latter resulting in Cdk1 
inactivation, removes the block on separase, which allows it to engage Scc1.  
The destruction of securin and cyclin B is brought about by the anaphase-
promoting complex or cyclosome (APC/C), a ubiquitin ligase, along with its 
activating subunit, Cdc20 (Irniger, et al. 1995; King, et al. 1995; Sudakin, et al. 
1995).  APC/CCdc20 ubiquitinates securin and cyclin B, which causes them to be 
recognized and destroyed by the 26S proteosome (Glotzer, et al. 1991).  The 
activity of APC/CCdc20 must be tightly regulated in order to ensure that cells do 
not prematurely progress from metaphase to anaphase causing changes in 
chromosome number in the daughter cells. 
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Figure 1 
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Figure 1.  Summary of SAC Signaling During Mitosis.  
Mitosis is subdivided into five consecutive phases:  prophase, prometaphase, 
metaphase, anaphase, and telophase.  To enter mitosis, the cell requires the 
activity of cyclin-dependent kinase 1 (CDK1), which depends on the binding of 
cyclin B to CDK1 (Peters 2006).  The protease activity of separase is required to 
remove the cohesin binding together sister chromatids in order for the cell to 
transition from metaphase to anaphase.  Prior to anaphase, separase is kept 
inactive by binding of the protein securin.  Unattached kinetochores contribute to 
the formation of the mitotic checkpoint complex (MCC), which inhibits the activity 
of Cdc20 to activate the APC/C.  Bipolar attachment of all sister chromatids 
inactivates the SAC, releasing Cdc20 to activate APC/C.  APC/C activation 
results in polyubiquitylation and destruction of cyclin B and securin.  Securin 
destruction results in the activation of separase, which cleaves the remaining 
cohesin holding together the sister chromatids.  Cyclin B degradation inactivates 
CDK1, initiating cytokinesis and mitotic exit. 
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During eukaryotic cell division, the accurate transmission of the genome is 
essential for survival of the daughter cells and is ensured by intrinsic properties 
of the cell cycle machinery and by a series of checkpoints (Gillett and Sorger 
2001).  Checkpoint mechanisms monitor cell cycle progression and guarantee 
faithful duplication and precise segregation of the genome (Li, et al. 1997).  The 
spindle assembly checkpoint (SAC), also known as the mitotic or spindle 
checkpoint, is a highly conserved signal transduction pathway that links the 
initiation of anaphase to spindle assembly and the completion of chromosome-
microtubule attachment (Dobles, et al. 2000; Hoyt, et al. 1991; Li and Murray 
1991; Li and Benezra 1996; Taylor and McKeon 1997).  The presence of even a 
single unattached or misaligned chromosome is sufficient to activate the SAC, 
which blocks the activity of the APC/C and arrests the cells at the transition from 
metaphase to anaphase (Hwang, et al. 1998; Kim, et al. 1998; Li and Nicklas 
1995; Li, et al. 1997; Rieder, et al. 1994).  Arrest caused by an unattached 
chromosome is overcome by laser ablation of the kinetochore, the structure that 
mediates chromosome-microtubule attachment (Rieder, et al. 1995), indicating 
that the signal for checkpoint-dependent arrest arises from, or is transduced 
through, kinetochores (Li, et al. 1997).  
 
Genes involved in the SAC were first identified in the budding yeast S. cerevisiae 
and include the mitotic arrest defective genes MAD1-3 (Li and Murray 1991) and 
the budding uninhibited by benzimidazole genes BUB1-3 (Hoyt, et al. 1991).  All 
six of these genes are dispensable for normal growth, apparently due to the fact 
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that mitosis in S. cerevisiae lasts long enough for all chromosomes to attach to 
the spindle before anaphase begins, even in the absence of a checkpoint.  The 
addition of anti-microtubule drugs causes the cells to proceed through mitosis 
without having established chromosome-microtubule attachment, resulting in 
extensive chromosome loss and cell death (Hoyt, et al. 1991; Li and Murray 
1991).  Homologues of these checkpoint proteins were later found in other 
organisms, including mammals (Table 1); these include Mad1, Mad2, 
Mad3/BubR1, Bub1, Bub3, and Mps1 (Yu 2002).  Upon isolation of the human 
homolog of MAD2, it was shown to be a necessary component of the mitotic 
checkpoint (Li and Benezra 1996).  All of these proteins, with the exception of 
Bub2, act in a complex signaling network that regulates Cdc20-APC/C and 
chromosome segregation (Gardner and Burke 2000).  In S. cerevisiae, Bub2 
appears to negatively regulate the mitotic exit network (MEN), which leads to the 
degradation of mitotic cyclins and other cell cycle regulators (Gardner and Burke 
2000).  The MEN is a signal transduction cascade, including several protein 
kinases, that ensures mitotic exit and cytokinesis is tightly coupled to nuclear 
division; this ensures that daughter cells inherit a complete set of chromosomes 
after cell division (Piatti, et al. 2006).  In eukaryotes, mitotic exit takes place after 
mitotic cyclin-dependent kinases (CDKs) are inactivated, which is normally 
fulfilled by cyclin proteolysis (Piatti, et al. 2006).  Inactivation of these CDKs in 
turn is necessary for spindle disassembly, licensing of replication origins, and 
cytokinesis (Piatti, et al. 2006). 
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Vertebrates S. cerevisiae Interactions & functions 
Mad1 Mad1 Binds to Mad2 and recruits Mad2 to kinetochores; 
phosphorylated by Mps1 & Bub1 in vitro 
Mad2 Mad2 Binds to Cdc20 & inhibits APC; binds to Mad1 
BubR1 Mad3 Binds to Bub3 & Ccd20; inhibits APC in vitro; binds to the 
mitotic motor CENP-E 
Bub1 Bub1 Binds to Bub3; binds to Mad1 & Cdc20 in S. cerevisiae; 
phosphorylates human Mad1 in vitro 
-- Bub2 Negatively regulates Tem1 and the mitotic exit network in 
S. cerevisiae 
Bub3 Bub3 Bind to Bub1 & BubR1 (Mad3) 
Mps1 Mps1 Phosphorylates Mad1 in S. cerevisiae 
Aurora B Ipl Binds to INCENP/Sli15/Pic1; promotes bi-orientation 
Cdc20 Cdc20 Binds to Mad2, BubR1(Mad3), Emi1, APC & APC 
substrates; activates APC; ubiquitinated by APC-Cdh-1; 
phosphorylated by Cdk1 in mammals 
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Table 1.  Components of the Spindle Assembly Checkpoint.   
These proteins, along with others, have been found to play a role in the SAC in 
yeast and/or vertebrates.   
  9 
Recognizing the Lack of Occupancy at the Kinetochore. 
The signaling process involved in the SAC, which is activated by the lack of 
tension and/or the lack of microtubule occupancy at the kinetochore, is quite 
complex.  Distinguishing between the contributions of attachment and tension to 
SAC activation is difficult, since interfering with creation of tension probably also 
affects attachment (Pinsky and Biggins 2005; Zhou, et al. 2002).  However, 
regardless of whether the SAC is regulated by tension independently of 
occupancy, kinetochore localization of checkpoint components is differentially 
regulated by occupancy and tension.  A single unattached kinetochore is 
sufficient to activate the SAC, and generates a ‘wait anaphase’ signal that must 
produce a signal to block APC activity (Rieder, et al. 1995).  This signal recruits 
SAC proteins to the unattached kinetochore (Vigneron, et al. 2004).  Aurora-
B/INCENP controls the localization of Mps1, Bub1, Bub3, and CENP-E at the 
kinetochores, and this localization, in turn, promotes the recruitment to the 
kinetochore of Mad1/Mad2, Cdc20, and the APC (Vigneron, et al. 2004).  Both 
Mad1 and Mad2 accumulate at unattached kinetochores and are removed upon 
microtubule attachment, and their localization signifies lack of attachment 
(Skoufias, et al. 2001). 
 
Recent studies have started to shed light on how a potential diffusible checkpoint 
signal inhibits APC.  There are two related models on how the SAC regulates the 
interaction of Cdc20 and the APC.  The APC is inhibited in both models through 
direct binding of the mitotic checkpoint complex (MCC), which contains BubR1, 
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Bub3, Mad2, and Cdc20 or the sub-complexes BubR1-Bub3-Cdc20 and Mad2-
Cdc20 (Fang 2002; Fang, et al. 1998; Fraschini, et al. 2001; Hardwick, et al. 
2000; Millband and Hardwick 2002; Sudakin, et al. 2001; Tang, et al. 2001); 
however, the two models differ in how the MCC assembles (Figure 2).  In one 
model (Figure 2A), the unattached kinetochores catalyze the formation of the 
MCC or its sub-complexes, which then diffuse away from the kinetochore to 
inhibit the APC (Skoufias, et al. 2001; Taylor, et al. 2001).  Both Mad2 and 
BubR1 appear to be able to bind Cdc20 directly, although they appear to have 
distinct binding sites on Cdc20 (Tang, et al. 2001; Wu, et al. 2000).  In the other 
model (Figure 2B), the MCC is present through all of the cell cycle and its 
formation does not occur at the kinetochores (Sudakin, et al. 2001).  Once the 
SAC is activated, an unknown diffusible signal turns over at the kinetochores and 
the APC is sensitized to inhibition by the MCC (Sudakin, et al. 2001). 
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Figure 2.  Models of APC Inhibition Through Binding of the Mitotic 
Checkpoint Complex (MCC) in Response to Lack of Attachment at the 
Kinetochore. 
Two related models exist on how the SAC regulates the interaction of Cdc20 and 
APC.  The APC is inhibited in both models through direct binding of the mitotic 
checkpoint complex (MCC), which contains BubR1, Bub3, Mad2, and Cdc20 or 
the sub-complexes BubR1-Bub3-Cdc20 and Mad2-Cdc20; however, the two 
models differ in how the MCC assembles.  (A) Numerous complexes of 
checkpoint proteins, including Mad1-Mad2, Bub1-Bub3, and Mad3/BubR1-Bub3, 
are detected throughout the cell cycle.  Other checkpoint complexes, such as 
BubR1-Bub3-Cdc20 and Mad2-Cdc20, seem to be enriched in mitotic cells, 
possibly due to the higher concentrations of Cdc20 in mitosis.  The unattached 
kinetochores catalyze the formation of the MCC or its sub-complexes, which then 
diffuse away from the kinetochore to inhibit the APC.  (B) The MCC is present 
through all of the cell cycle but is incapable of inhibiting the APC until it has 
undergone mitotic modifications.  Once the SAC is activated, an unknown 
diffusible signal turns over at the kinetochores and the APC is sensitized to 
inhibition by the MCC.  In both models, binding of microtubules to kinetochores 
leads to dissociation of the MCC from the APC.  This activates that APC, 
allowing the cell to progress through M-phase.
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Regulation of Kinetochore-Microtubule Attachments in Lack of Tension. 
The lack of tension may activate specific subsets of checkpoint proteins, 
including Ipl1/Aurora-B (Biggins and Murray 2001).  The chromosomal passenger 
complex (CPC) is composed of Aurora-B and three non-enzymatic subunits, 
INCENP, survivin, and borealin (Gassmann, et al. 2004; Honda, et al. 2003; 
Klein, et al. 2006; Sampath, et al. 2004).  INCENP (inner centromere protein) 
appears to act as a scaffold, interacting with the other three members of the 
complex (Adams, et al. 2000; Gassmann, et al. 2004; Kim, et al. 1999; Wheatley, 
et al. 2001).  The C terminus of INCENP is involved in the binding and regulation, 
more specifically the activation, of Aurora-B (Adams, et al. 2000; Kaitna, et al. 
2000).  Aurora-B/Ipl1 is a highly conserved Ser/Thr kinase (Terada, et al. 1998) 
and it phosphorylates Tousled-like kinase-1 (TLK-1) during prophase-
prometaphase and this, in turn, increases Aurora-B activity in an INCENP 
dependent manner (Han, et al. 2005).  The yeast kinase Ipl1 is required for 
establishing bi-orientation and tension of sister chromatids (Tanaka 2002; 
Tanaka, et al. 2002), and might also sense the lack of tension at kinetochores 
(Biggins and Murray 2001; Stern 2002).  Aurora-B, the mammalian homologue of 
Ipl1, has been shown to be required for bipolar attachment of chromosomes and 
for proper function of the SAC in mammalian cells (Kallio, et al. 2002; Murata-
Hori, et al. 2002; Murata-Hori and Wang 2002).  Survivin is a conserved member 
of the inhibitor of apoptosis protein (IAP) family and contains a baculovirus IAP 
repeat (BIR) domain that is responsible for its dimerization (Chantalat, et al. 
2000; Muchmore, et al. 2000; Verdecia, et al. 2000).  Survivin can bind to the 
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other three members in the CPC complex and is phosphorylated by Aurora-B 
(Carvalho, et al. 2003; Wheatley, et al. 2004).  Borealin was identified in a 
proteomic screen for new components of the mitotic chromosome scaffold and is 
phosphorylated by Aurora-B in vitro (Gassmann, et al. 2004).  The CPC has 
various functions during mitosis and meiosis, ranging from monitoring 
chromosome-microtubule interactions to sister chromatid cohesion to cytokinesis, 
but its role in kinetochore attachment and chromosome segregation are of 
particular interest in further understanding the ability of the CPC to sense the lack 
of tension. 
 
The CPC is required for proper chromosome bi-orientation at metaphase 
(Adams, et al. 2001; Gassmann, et al. 2004; Kaitna, et al. 2000), and is a key 
component in detecting aberrant kinetochore-microtubule attachments and, 
particularly, a lack of tension across the spindle (Kotwaliwale and Biggins 2006).  
This may involve the phosphorylation of key kinetochore-centromere components 
by Aurora-B, although INCENP and survivin may also be involved.  In yeast, the 
kinetochore is composed of protein complexes that are classified as inner, 
central, or outer kinetochore complexes (Tan, et al. 2005).  The DAM1 [Duo1 - 
and Mps1 (monopolar spindle 1) - interacting] complex, an outer kinetochore 
complex, plays a crucial role in mediating the kinetochore-microtubule 
connection, and is regulated through phosphorylation by the Ipl1/Aurora-B kinase 
(Tan, et al. 2005).  Like Dam1, Ipl1 and Sli15/INCENP each bind microtubules in 
vitro (Tan, et al. 2005).  Because of their association with both kinetochores and 
  15 
microtubules, the Ipl1 and DAM1 complexes are believed to regulate various 
aspects of chromosome-spindle interaction (Kang, et al. 2001).  The Ipl1 complex 
responds to the lack of tension in monotelic attachments, and acts to resolve 
these inappropriate attachments, probably through its substrates (Biggins, et al. 
1999; Buvelot, et al. 2003; Cheeseman, et al. 2002).  The ipl1 kinase 
phosphorylates Ndc10p in vitro, suggesting that Ipl1p regulates the kinetochore 
by phosphorylating Ndc10p (Biggins, et al. 1999).  Ndc10p, along with Cep3p, 
Ctf13p, and Skp1, make up the CBF3 complex (Kaplan, et al. 1997; Lechner and 
Carbon 1991; Stemmann and Lechner 1996).  The CBF3 complex binds to 
centromeric DNA and this interaction is essential for kinetochore function 
(Lechner and Carbon 1991; Sorger, et al. 1995).  The CBF3 complex does not 
bind microtubules, but beads coated with centromeric DNA-CBF3 complexes can 
bind to microtubules after they have been incubated in yeast extracts (Sorger, et 
al. 1994), suggesting that CBF3 can recruit unknown microtubule-binding 
proteins to the kinetochore.  These unknown binding proteins were later identified 
as an INCENP-survivin complex (Sandall, et al. 2006).  It has been shown that 
the interaction between Ndc80 and DAM1 proteins is essential for the association 
of the DAM1 complex with kinetochores, and that the DAM1-Ndc80 binding 
affinity is weakened by Ipl1-mediated phosphorylation (Shang, et al. 2003).  In 
the absence of tension, Ipl1 causes an increased turnover of kinetochore-
microtubule connections, perhaps by influencing the Ndc80-DAM1 interaction, in 
this manner facilitating eventual bi-orientation of chromosomes (Cheeseman, et 
al. 2002; Shang, et al. 2003; Tanaka, et al. 2002).  In addition, Ipl1 may also 
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regulate the assembly of the DAM1 complex itself (Cheeseman, et al. 2002).  
Recent data suggest that the MTW1 complex promotes kinetochore bi-
orientation, which is monitored by the Ipl1 kinase (Pinsky, et al. 2003).  The 
tension sensing mechanism might also involve the kinetochore-associated 
microtubule motor protein CENP-E, which binds to spindle microtubules and 
BubR1, allowing it to modulate signaling activity in a microtubule-dependent 
manner (Abrieu, et al. 2000).  Stable association of BubR1 to kinetochores and 
sustained checkpoint signaling in response to lack of tension appears to depend 
on survivin (Lens, et al. 2003), further implicating the CPC in this process. 
 
An important target of Aurora-B in the vertebrate kinetochore is HEC1 (highly 
expressed in cancer-1; Ndc80 in yeast), which is required for kinetochore-
microtubule interactions and chromosome segregation (DeLuca, et al. 2003).  
HEC1, along with KNL-1 (Kinetochore NuL-1) and the Mis12 complex, appear to 
make up the KMN complex, which is essential for microtubule binding to the 
kinetochore (Cheeseman, et al. 2006).  Aurora-B phosphorylation of 
HEC1/Ndc80 in the KMN complex appears to lead to microtubule release by the 
kinetochore in the presence of inappropriate attachments (Cheeseman, et al. 
2006; DeLuca, et al. 2006).  The kinesin 13 microtubule depolymerase MCAK 
(mitotic centromere-associated kinesin) is also involved in bipolar spindle 
assembly (Ohi, et al. 2004; Tulu, et al. 2006).  Aurora-B phosphorylation of 
MCAK inhibits microtubule depolymerization activity (Andrews, et al. 2004; Lan, 
et al. 2004).  The CPC is specifically enriched at non-attached and merotelically 
  17 
(a single kinetochore binding to microtubules from both spindle poles) attached 
kinetochores (Knowlton, et al. 2006; Vagnarelli and Earnshaw 2004).  Studies 
suggest that Aurora-B promotes MCAK accumulation and regulates its activity at 
there aberrant attachments (Andrews, et al. 2004; Lan, et al. 2004). 
 
Overall, it appears that microtubule binding by kinetochores is very complex, 
involving a network of redundant weak interactions (Ruchaud, et al. 2007).  
HEC1/Ndc80 and the KMN network may be important for creating low-affinity 
links that can be released through the action of the CPC, in particular Aurora-B 
(Figure 3) (Cheeseman, et al. 2006).  The low-affinity links that involve INCENP 
and survivin appear to enable kinetochores to sense tension within the mitotic 
spindle.  MCAK uses its ability to destabilize microtubules to release undesirable 
kinetochore-microtubule attachments, even in the presence of normal local 
tension within the spindle.  It is clear that the CPC, with Aurora-B as its kinase, is 
the regulator of kinetochore-microtubule attachments that control essential 
mechanisms of microtubule release.  After the CPC and other proteins release 
improper kinetochore-microtubule attachments, other SAC signaling pathways 
can sense the lack of attachment at the kinetochore and arrest the cell before it 
transitions to anaphase. 
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Figure 3 
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Figure 3.  The Chromosomal Passenger Complex (CPC) Corrects Incorrect 
Microtubule Attachments and Indirectly Activates the SAC. 
To obtain bipolar spindle attachment, improper attachments (syntelic and 
merotelic attachments) must be corrected to prevent chromosome 
missegregation.  The CPC, mainly the kinase activity of Aurora-B, is required for 
this correction process.  Aurora-B phosphorylates kinetochore proteins that bind 
to microtubules, modifying the affinity or stability of kinetochore-microtubule 
interactions.  As a result, microtubules detach from the kinetochore allowing new 
microtubule attachments until bipolar attachments are obtained.  During this 
process, unattached kinetochores are capable of activating the SAC and 
inhibiting the APC. 
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The Importance of Mad2 in the SAC. 
The principal system for regulating the APC/C-Cdc20 interaction in response to 
the kinetochore-microtubule attachment status is the SAC (Homer 2006; 
Musacchio and Hardwick 2002; Taylor, et al. 2004).  One model regarding SAC 
function hypothesizes that in response to kinetochores which lack microtubule 
attachment and/or tension, the primary downstream effect of SAC activation is 
the generation of a conformation of Mad2 capable of sequestering cellular 
Cdc20, thereby preventing APC/C activation and hence cell cycle progression 
(De Antoni, et al. 2005; Nasmyth 2005).  This model takes into account that 
either lack occupancy or tension alone may be too simplistic to explain the 
signaling that occurs during SAC activation.  Syntelic chromosomes, 
chromosomes with both sister chromatids attached to the same pole, often retain 
Mad2 at their kinetochores (Kapoor, et al. 2000), suggesting that attachment is 
not enough to silence the SAC.  Furthermore, even though Mad2 is not found at 
kinetochores in taxol-treated cells, which lack tension across the mitotic spindle, 
it is still required to keep the cells arrested in M-phase (Waters, et al. 1998).  In 
budding yeast, Mad2 was found to be required for cells to respond to lack of 
attachment or tension during mitosis (Shonn, et al. 2000) and meiosis (Stern and 
Murray 2001).  Although the complete mechanism of SAC signaling in response 
to improperly attached kinetochores remains incompletely resolved, the net effect 
is indisputably APC/C-Cdc20 inhibition for which Mad2 is of central importance 
(Homer 2006).  
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Of the proteins involved in the spindle assembly checkpoint, Mad2 appears to be 
the most crucial protein for generating the wait anaphase signal that prevents the 
onset of anaphase in the presence of microtubule disruption (Amon 1999; Li and 
Benezra 1996; Wassmann and Benezra 2001).  Mad2 null (Mad2-/-) embryos die 
in utero about 6.5-7.5 days after conception (E6.5-E7.5) (Dobles, et al. 2000).  
However, Mad2-/- embryos appear normal in utero and in culture until embryonic 
day E5.5 (Dobles, et al. 2000).  These cells are unable to arrest in mitosis in 
response to drug induced spindle disruption, demonstrating they lack a functional 
spindle assembly checkpoint (Dobles, et al. 2000).  Mad2 null cells proceed to 
anaphase even when unattached chromosomes are present, leading to 
missegregation of chromosomes and resulting in apoptotic cell death (Dobles, et 
al. 2000).  Deletion of one allele of the Mad2 gene results in premature 
separation of sister chromatids and high frequency of chromosome 
missegregation in the presence of nocodazole, a microtubule-destabilizing agent 
and spindle inhibitor, in both primary murine embryonic fibroblasts and human 
cancer cells (Michel, et al. 2001).  Mad2+/- mice exhibit increased germinal center 
formation in the spleen and a possible increase in tumor incidence when 
compared to age-matched Mad2+/+ mice (Dobles, et al. 2000).  Also, subtle 
differences in morbidity rates occur between the colonies of Mad2+/+ and Mad2+/- 
mice, but overall the Mad2+/- animals appear largely normal (Dobles, et al. 2000).  
Even though the hematopoietic system of the Mad2+/- animals was not fully 
examined in these initial studies of Mad2, it was later shown to play a role in 
optimal hematopoiesis (Ito, et al. 2007). 
  22 
Examining the Role of the SAC and Mad2 in Hematopoiesis. 
The mammalian hematopoietic system is a complex tissue made up of various 
cell types capable of performing a wide range of functions, such as protection 
against infection and oxygen and nutrient delivery.  All cells that make up the 
blood and immune system originate from hematopoietic stem cells (HSC) (Figure 
4), which have the ability to renew themselves and differentiate, consequently 
providing a source of blood cells for the entire life of the organism.  
Understanding genome maintenance and possible causes of chromosomal 
instability (CIN) in hematopoietic cells during ex vivo expansion and 
transplantation is necessary to ensure their safe and effective use.  Before 
further examining the specific role of Mad2 in hematopoiesis, the functionality of 
the SAC in HSCs needs to be determined.  Both mouse and human embryonic 
stem cells (ESC) were found to exhibit checkpoint apoptosis uncoupling (Mantel, 
et al. 2007).  When ESCs were treated with nocodazole to activate the SAC, they 
did not initiate apoptosis; instead, the ESCs exit mitosis and cycle in culture for a 
period of time as a polyploid population (Mantel, et al. 2007).  These cells also 
appear to undergo tetraploid cell division, cycling between 4C and 8C DNA 
content, and upon differentiation, the polyploid ESCs initiate caspase dependent 
apoptosis (Mantel, et al. 2007).  Understanding how the SAC functions in HSCs 
and if its activation leads to apoptosis initiation will be important to understand 
before examining the specific role Mad2 plays in this checkpoint. 
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Figure 4 
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Figure 3.  The Hierarchy of Hematopoietic Cells. 
Hematopoietic stem cells are multipotent cells that can give rise to all the various 
lineages of blood cells, including myeloid and lymphoid lineages.  The HSC 
population contains both long-term and short-term repopulating HSC; MPP, 
multipotent progenitor; CMP, common myeloid progenitor; CLP, common 
lymphoid progenitor; MEP, megakaryocyte/erythroid progenitor; GMP, 
granulocyte/macrophage progenitor.  The pluripotent population of HSC and 
MPP are Lin-, Sca-1+, c-kit+. 
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Limited work has been done examining Mad2 and its role in hematopoiesis (Li, et 
al. 1997), and further examination of this protein could provide more important 
information on the function of Mad2 in hematopoiesis.  Mad2 protein levels in 
bone marrow (BM) low-density mononuclear cells (LDMC) are reduced by half in 
Mad2+/- mice as compared to Mad2+/+ mice (Ito, et al. 2007).  When the colony 
forming ability of these cells was examined, Mad2+/- BM and spleen manifested 
decreased absolute numbers and cycling status of immature, but not mature 
hematopoietic progenitor cells (Ito, et al. 2007).  In addition, Mad2+/- BM 
granulocyte-macrophage colony-forming units (CFU-GM) did not proliferate 
synergistically in response to stem cell factor (SCF) plus GM-CSF.  Through the 
use of immunoprecipitation assays and confocal microscopy, Mad2 was found to 
associate with the c-kit receptor in the cytoplasm in the human growth factor-
dependent cell line MO7e.  The function of the hematopoietic progenitor cells 
(HPC) was looked at this study, but how Mad2 haploinsufficiency affects the 
ability of HSCs to compete and self-renew was not examined. 
 
Investigation of the Role Ape1/Ref-1 Plays in Hematopoiesis. 
Apurinic/apyrimidinic endonuclease/redox factor 1, Ape1/Ref-1 (referred to here 
as APE1), is a multifunctional protein possessing both DNA repair and 
transcriptional regulatory activities.  APE1 was first identified as a DNA repair 
enzyme by two independent groups (Demple, et al. 1991; Robson and Hickson 
1991) and was subsequently found to also have redox function (Xanthoudakis 
and Curran 1992).  APE1 acts as the major apurinic/apyrimidinic endonuclease 
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in the base excision repair (BER) pathway.  APE1 is also a transcriptional 
regulator of gene expression by acting as a redox co-activator of transcription 
factors, including early growth factor response protein-1 (Egr-1), p53, hypoxia 
inducible factor-1α (HIF-1α), and activator protein-1 (AP-1) (Huang and Adamson 
1993; Jayaraman, et al. 1997; Lando, et al. 2000; Xanthoudakis and Curran 
1992).  These two activities are located in two functionally distinct domains 
(Xanthoudakis, et al. 1994).  The N-terminus is dedicated to redox function, 
through cysteine (Cys) 65, and the C-terminus is responsible for the enzymatic 
activity on abasic sites found in DNA.  Although the endonuclease activity found 
in the C-terminus is highly conserved, the N-terminus containing the redox 
activity is not.  APE1 is the human homologue of E. coli exonuclease III protein 
(Demple, et al. 1991; Robson and Hickson 1991); mammalian APE1 contains a 
61-residue N-terminal domain essential for redox activity that is absent from the 
bacterial homologue (Walker, et al. 1993; Xanthoudakis, et al. 1994).  It was 
hypothesized that the redox activity of APE1 could potentially involve a Cys 
residue (Xanthoudakis, et al. 1994).  When each of the Cys residues in APE1 
were individually substituted with alanine (Ala), only C65A hApe1 was redox 
inactive (Walker, et al. 1993), suggesting that Cys 65 is important for redox 
activity.  In zebrafish Ape (zApe), the residue equivalent to mammalian Ape Cys 
65 is threonine (Thr) 58; however, when wild-type zApe enzyme was tested for 
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redox activity, it was found to be inactive (Georgiadis, et al. 2008).  The 
replacement of Thr 58 with Cys in zApe resulted in a redox active enzyme, 
further suggesting that a Cys residue at this position is critical for redox function 
(Georgiadis, et al. 2008). 
 
The physiological relevance of APE1 was investigated by the creation of mice 
lacking a functional ref-1 gene (Xanthoudakis, et al. 1996).  Homozygous mutant 
mice die during early embryonic development; death occurs following blastocyst 
formation, shortly after the time of implantation (Xanthoudakis, et al. 1996).  
Degeneration of homozygous mutant embryos is evident by embryonic day 5.5, 
indicating that APE1 is essential for early embryonic development (Xanthoudakis, 
et al. 1996).  In contrast, heterozygous mutant mice develop into adulthood with 
no apparent abnormalities (Xanthoudakis, et al. 1996).  Attempts to isolate stable 
APE1-knockout cell lines have been unsuccessful to date, making the complete 
understanding of the molecular targets of APE1 very complicated (Tell, et al. 
2009).  While several conditional knockout and knockdown strategies have 
recently been developed (Fung and Demple 2005; Izumi, et al. 2005), which 
verify the importance of APE1 in cell survival, the understanding of the molecular 
targets it regulates is still not comprehensive.  Initially, the importance of APE1 to 
cell viability appeared to be due to its DNA repair activity in the BER pathway 
(Fung and Demple 2005); however, this hypothesis may not be completely true.  
Attempts to restore APE1 activity to cells not expressing this protein by using the 
yeast homologue Apn1 (Fung and Demple 2005), which lacks the redox-
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transcriptional domain found in the mammalian protein, or an APE1 mutant 
lacking acetylation sites but not DNA repair activity (Izumi, et al. 2005), were not 
successful.  These observations imply that both the redox functions and DNA 
repair activities of APE1 are essential to the role it plays in cell viability. 
 
Several knockdown studies utilizing siRNA have been helpful in examining the 
role of APE1 in normal and cancer cells (Chen and Olkowski 1994; Evans, et al. 
2000; Ono, et al. 1994; Walker, et al. 1994), but these studies do not reveal the 
individual role of the DNA repair or redox functions of APE1.  Knockdown of 
APE1 removes not only its redox signaling function, but also its DNA repair 
function and protein-protein interactions with other DNA repair and other proteins 
independent of the redox or DNA repair functions.  E3330, an anti-NF-κB drug, 
was found to target Ref-1 (Hiramoto, et al. 2002; Shimizu, et al. 2000).  E3330 
has been shown to be a highly specific inhibitor of Ape1/Ref-1 redox activity, 
without affecting the repair endonuclease activity (Luo, et al. 2008).  E3330 does 
not increase the percentage of cells undergoing apoptosis, but rather blocks both 
normal and cancer cell growth by stopping cell proliferation (Fishel, et al. 2010; 
Luo, et al. 2008).  While use of this specific small molecule inhibitor of APE1 
redox is not directly comparable to siRNA knockdown studies, this specific 
inhibitor does allow the redox function of APE1 to be examined separately from 
its DNA repair activity. 
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The role that the redox function of APE1 plays in cellular functions has been 
examined in many settings, particularly in cancer cells as a therapeutic agent 
(Fishel, et al. 2010; Zou, et al. 2009; Zou and Maitra 2008); however little work 
has been done examining the role that APE1 redox function plays in normal 
hematopoiesis.  A study in mouse embryonic stem (ES) cells and ES cell-derived 
embryoid body (EB) cells revealed that siRNA knockdown of APE1 expression 
induced G1 arrest and decreased the percent of ES cells in S-phase, indicating 
APE1 regulates cell-cycle status in ES cells and also positively regulates the 
G1/S transition of the cell cycle in EB cells (Zou, et al. 2007).  Knockdown of 
APE1 in EB cells was also shown to decrease hemagioblast formation, as well as 
diminish formation of primitive and definitive hematopoietic colonies (Zou, et al. 
2007).  Through the use of E3330, it was found that the redox function, but not 
the DNA repair activity, of APE1 is required for normal embryonic hematopoiesis 
(Zou, et al. 2007).  The redox function of this protein has not been thoroughly 
evaluated in normal adult hematopoiesis. 
 
Research Goals. 
We first wanted to determine if the SAC was functional in hematopoietic cells, 
and if its activation would lead to the initiation of apoptosis.  Previous data shows 
that the SAC is uncoupled from apoptosis initiation in mouse and human ESCs 
(Mantel, et al. 2007).  ESCs exit mitosis and become polyploid after prolonged 
activation of the SAC; ESCs accumulate in M-phase of the cell cycle after 
microtubule disruption with nocodazole, but exit mitotic delay and re-enter a 
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polyploid mitosis (Mantel, et al. 2007).  This is in contrast to normal somatic cells 
and cell lines with normal p53 responses, which do not respond to prolonged 
activation of the SAC in this manner.  These cells initiate apoptosis after exiting 
the cell cycle in a G0/G1-like state with 4C DNA content, often in two nuclei, or 
enter senescence (Lanni and Jacks 1998; Lanni, et al. 1997).  These data, along 
with findings of increased pseudomitotic index in neural and hematopoietic 
progenitor cells (Damelin, et al. 2005), suggest that the SAC might also be 
uncoupled from apoptosis in HSCs.  Proper function of the SAC is vital to prevent 
polyploidy/aneuploidy during ex vivo culture and expansion of HSC and their 
progenitors. 
 
We were interested in further studying the function of Mad2 in mammalian 
hematopoiesis for two reasons.  First, differentiated cells in many tissues have a 
relatively short life span and are continuously replaced by new cells generated 
from progenitor cells (Damelin, et al. 2005).  In human bone marrow, 
approximately 200 billion erythrocytes and 70 billion neutrophilic leukocytes are 
produced and released into the bloodstream every day (Gunsilius, et al. 2001).  
Because HSCs and subsequently HPCs give rise to all the cells in the 
hematopoietic system, it is of special importance that these cells accurately 
transmit their genome to their many progeny and that their checkpoints function 
properly.  Therefore, we were interested in studying HSCs to determine if Mad2 
haploinsufficiency adversely affects the stem cell’s ability to self-renew and 
differentiate into multiple lineages.  The process of stem cell self-renewal is not 
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completely understood.  It is hypothesized that the stem cell must divide in a way 
that maintains pluripotency in at least one of the daughter cells.  This type of 
division, an asymmetrical division, most likely occurs through the segregation of 
cell fate determinants, which is established by the spindle orientation during 
mitosis (Piatti, et al. 2006).  Since positioning of the spindle is also part of the 
spindle assembly checkpoint (Mantel, et al. 2008), Mad2 haploinsufficiency could 
affect this aspect of the cell cycle, and therefore, cause problems in stem cell 
self-renewal and differentiation.  Second, chromosomal instability (CIN) leading 
to an aberrant chromosome number (aneuploidy) is a hallmark of many cancers 
(Bharadwaj and Yu 2004; Jallepalli and Lengauer 2001), but the mechanism and 
molecular determinants promoting CIN are not clearly understood (Jallepalli and 
Lengauer 2001).  There is increasing evidence that suggests a role of the SAC in 
promoting aneuploidy and tumorigenesis (Taylor, et al. 2004).  It is possible that 
Mad2 haploinsufficiency could cause defects in both processes involved in the 
spindle assembly checkpoint:  the first timer delaying the onset of anaphase until 
all chromosome are properly aligned, and the second timer regulating cytokinesis 
and mitotic exit.  Deficiencies in either one or both of these timers could 
potentially lead to chromosome missegregation and aneuploidy in the Mad2+/- 
cells.  Mad2+/- mice develop lung tumors at high rates after long latencies, 
implicating defects in the spindle assembly checkpoint in tumorigenesis (Michel, 
et al. 2001).  Decreased expression of Mad2 in colon cancer cells, along with 
other spindle checkpoint proteins, causes deficiencies in SAC activation; this 
leads to mitotic aberrations including improper alignment of chromosomes at the 
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metaphase plate, lagging chromosomes during anaphase, anaphase/telophase 
chromatin bridges, multipolar divisions, and formation of polynucleated (Payne, 
et al. 2010).  
 
Previous studies in our laboratory found a higher percentage of cell death in KL 
(c-kit+, lin-) BM of Mad2+/- mice compared to Mad2+/+ BM, when cells were 
cultured in SCF and GM-CSF (Ito, et al. 2007).  However, there was no 
significant difference between Mad2+/- and Mad2+/+ mice in the percentage of cell 
death of BM cells before cell culture, suggesting that greater cell death may 
occur in Mad2+/- HPC in stress conditions but not in steady state conditions (Ito, 
et al. 2007).  To determine if Mad2+/- cells are more sensitive than Mad2+/+ cells, 
we treated Mad2+/- and Mad2+/+ mice with various cytotoxic agents and examine 
the in vivo cytotoxic effects these agents have on HPC colony formation. 
 
It was reported that the redox function, but not the DNA repair activity, of APE1 is 
required for normal embryonic hematopoiesis (Zou, et al. 2007); however, the 
redox function of this protein has not been thoroughly evaluated in normal adult 
hematopoiesis.  Using E3330, we examined the effect that inhibiting the redox 
function of APE1 has on normal adult hematopoiesis and also on sub-optimal 
hematopoiesis. 
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MATERIALS AND METHODS 
 
Mice.   
Mad2+/+ wild-type and Mad2+/- mutant mice were originally generated by 
interbreeding the wild-type and mutant mice kindly provided by Dr. Robert 
Benezra (Memorial Sloan-Kettering Cancer Center, New York, NY).  These mice 
were backcrossed with C57Bl/6J (Bl/6; CD45.2) mice (Jackson Laboratories, Bar 
Harbor, ME, USA) for at least 8 generations in our animal housing facility before 
experimental use.  All of the mice were used at 6 to 10 weeks of age.  For 
competitive repopulation assay, C57/BoyJ F1 (F1; CD45.1/CD45.2) and B6.SJL-
PtrcaPep3b/BoyJ (Boy J; CD45.1) mice were obtained from an on-site core 
breeding colony.  The Institutional Animal Care and Use Committee of the 
Indiana University School of Medicine approved all experimental procedures. 
 
Cytokines, Antibodies, and Other Agents.   
Purified recombinant preparations of murine (rmu) granulocyte macrophage-
colony stimulating factor (GM-CSF) and stem cell factor (SCF) were purchased 
from R&D Systems (Minneapolis, MN).  Purified recombinant human (rhu) 
erythropoietin (Epo) was purchased from Amgen (Thousand Oaks, CA).  
Thrombopoietin (TPO) was purchased from Genentech (Oceanside, CA) and rhu 
FMS-like tyrosine kinase 3 ligand (Flt3) was purchased from Immunex (Seattle, 
WA).  Pokeweed mitogen mouse spleen cell-conditioned medium (PWMSCM) 
was prepared as described (Cooper and Broxmeyer 1991). 
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For flow cytometric analysis, anti-mouse antibodies c-Kit, Sca-1, FcγR III/II, IL-
7Rα, Lineage Cocktail (CD3e, CD11b, CD45R/B220, Erythroid Cells, and Ly-6G 
and Ly-6C), secondary antibodies, and isotype controls were purchased from BD 
Biosciences (San Diego, CA).  Anti-mouse CD34 (cluster of differentiation 
molecule 34) antibody was purchased from eBioscience (San Diego, CA) and 
Sca-1 was also purchased from BioLegend (San Diego, CA).  Hoechst 33342 
used for staining DNA was obtained from Invitrogen (Carlsbad, CA).  Antibodies 
to phospho-histone H3 (Ser10) and cleaved caspase 3 (Asp175) were purchased 
from Cell Signaling Technology (Danvers, MA).  Cytofix/Cytoperm™ 
Fixation/Permeabilization Solution Kit was purchased from BD Biosciences (San 
Diego, CA). 
 
The following drugs purchased from Sigma-Aldrich (St. Louis, MO) were used to 
stress mice and examine BM progenitor recovery:  cyclophosphamide 
monohydrate (cytoxan) and cytarabine (Ara-C).  To condition mice before BM 
transplantation or examine BM recovery, γ-radiation (137Cs source, single dose) 
was used.  E3330 was kindly provided by Dr. Mark R. Kelley; its synthesis has 
been previously described (Luo, et al. 2008). 
 
Histological Analysis. 
Spleen, liver, and other masses were collected from four wild-type mice and 
eleven Mad2+/- mice.  Fresh tissue were prepared for histological analysis by 
freezing in peel away embedding molds (Electron Microscopy Sciences, Hatfield, 
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PA) with Tissue-Tek® O.C.T. Compound (Ted Pella, Inc., Redding, CA) on dry 
ice.  The Clarian Pathology IHC Core Laboratory prepared slides of the tissue 
samples for histological analysis.  Histology was performed on frozen tissue 
sections that were stained with hematoxylin and eosin (H&E) to show 
extramedullary hematopoiesis in spleen, liver, or other sites.  Slides were kindly 
analyzed by Dr. Atillio Orazi (Weill Medical College of Cornell University and New 
York-Presbyterian Hospital, New York, NY). 
 
Isolation and Culture of LDMCs From Murine BM.   
Murine BM was isolated from both femurs of mice using aseptic procedures.  
Low-density mononuclear cells were isolated by Lympholyte®-M (Cedarlane 
Laboratories Ltd., Burlington, NC) separation.  Cells were washed three times 
with phosphate buffered saline (PBS) and resuspended in Roswell Park 
Memorial Institute medium (RPMI) + 10% heat inactivated fetal bovine serum 
(FBS) + 100 ng/ml each of TPO, Flt3, and SCF and then incubated at 37ºC for 24 
hours before treatment with nocodazole (Sigma-Aldrich, St. Louis, MO).  The 
drug was dissolved and diluted in dimethyl sulfoxide (DMSO), and the 
concentration of nocodazole used in experiments was 1 ng/ml. 
 
Multivariate Permeablized Flow Cytometry.   
After harvesting and washing with PBS, single cell suspensions were stained 
with primary antibodies, followed by staining with secondary antibodies each for 
30 minutes in the dark.  Cells suspensions were washed three times with PBS + 
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1% bovine serum albumin (BSA) after primary and secondary staining.  Cells 
were permeablized and fixed using Cytofix/Cytoperm™ Fixation/Permeabilization 
solution and then stained with various antibodies to phospho-histone H3 or 
cleaved caspase 3, washed with Perm/Wash Buffer, and counterstained with 
Hoechst 33342.  Flow cytometric data was acquired using an LSR II (BD, San 
Diego, CA) analyzer.  Data was analyzed with WinList program (Verity Software 
House, Topsham, ME).   
 
Phenotypic Analysis.   
The following hematopoietic stem and progenitor populations were assessed in 
Mad2+/+ and Mad2+/- BM as previously described (Katsumoto, et al. 2006):  
lineage- sca-1+ c-kit+ IL-7Rα- cells (a population enriched for HSC), common 
lymphoid progenitor (CLP; Lin- Sca-1+ c-kit+ IL-7Rα+), megakaryocyte/erythroid 
progenitor (MEP; Lin- Sca-1- c-kit+ CD34- FcγR-/lo), common myeloid progenitor 
(CMP; Lin- Sca-1- c-kit+ CD34+ FcγR-/lo), and granulocyte/macrophage progenitor 
(GMP; Lin- Sca-1- c-kit+ CD34+ FcγR+/hi).  Bone marrow from mice was collected 
and stained with antibodies to surface markers previously described.  Data was 
collected from the samples using an LSR II (BD, San Diego, CA) and BD 
FACSDiva software (BD, San Diego, CA).  Data was analyzed using WinList 
software (Verity Software House, Topsham, ME). 
 
  37 
Clonogenic Progenitor Cell Assay.   
Bone marrow from mice was assessed for colony-forming unit granulocyte-
macrophage (CFU-GM), erythroid burst-forming unit (BFU-E), and multipotential 
granulocyte, erythroid, monocyte, megakaryocyte CFU (CFU-GEMM) progenitor 
cells, as described elsewhere (Broxmeyer, et al. 2005).  In short, for 
methylcellulose assays, 5 x 104 BM cells or 5 x 105 spleen cells were plated and 
cultured in 0.9% methylcellulose culture medium with 30% non-heat inactivated 
FBS (Hyclone Laboratories, Logan, UT), 5% vol/vol PWMSCM, 50 ng/mL 
rmuSCF, 1 U/mL rhuEpo, 2 mM glutamine (Cambrex Bio Science, Walkersville, 
MD), 10-4 M 2-mercaptoethanol, and 0.1 mM hemin (Sigma-Aldrich, St. Louis, 
MO).  For single cytokine assays, 5 x 104 cells were plated and cultured in 0.3% 
methylcellulose culture medium in the presence of 50 ng/mL rmuSCF, 10 ng/mL 
rmuGM-CSF, or a combination of the two.  All test groups were plated in 
triplicate.  Colonies were scored after 7 days of incubation at 37ºC, in 5% O2 and 
5% CO2, unless otherwise noted.  Absolute numbers of progenitors were 
calculated from the nucleated cellularity per femur and the number of colonies 
formed per number of cells plated.  The percentage of progenitors in the S-phase 
of the cell cycle was estimated by use of the tritiated thymidine kill technique, as 
described previously (Cooper, et al. 1994).  For assays examining the effect of 
E3330 on colony formation, 5 x 104 BM cells were incubated with varying 
concentrations of the inhibitor for 4 hours at 37ºC prior to plating in 
methylcellulose as described above.  Colonies were scored after 7 days of 
incubation at 37ºC, in either 20% and 5% CO2 or 5% O2 and 5% CO2. 
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Recovery of BM Progenitors From Cytotoxic Effects.   
Mad2+/+ and Mad2+/- mice were treated with cyclophosphamide/cytoxan (200 
mg/kg, intraperitoneal (i.p.)), high sub-lethal levels of γ-irradiation (650 cGy whole 
body irradiation), or Ara-C (500 mg/kg, subcutaneously (s.c.)) on day zero of the 
experiment.  For the mice treated with Ara-C, we analyzed mice at days 1, 3, and 
5 after injection.  Mice treated with cytoxan were analyzed on days 1, 3, 5, and 7 
after injection.  Mice treated with γ-irradiation were analyzed on days 7, 10, and 
14 after irradiation.  For each treatment, both control Mad2+/+ and Mad2+/- mice 
were assessed at day zero without any treatment.  For each treatment used, the 
days that we examined have been shown by our laboratory and others to be 
optimal for assessing rebound hematopoiesis (Broxmeyer, et al. 1976; 
Broxmeyer, et al. 2006; DeWys, et al. 1970; Hromas, et al. 2002; Radley and 
Scurfield 1979).  For analysis, BM and spleen were aseptically harvested from 
the treated mice at the various time points stated above, and colony assays 
performed as previously described. 
 
Competitive Repopulation Assay.   
Estimation of stem cell function in lethally irradiated hosts was performed using a 
competitive repopulation assay (CRA) as adapted from Harrison and colleagues 
(Harrison 1980; Harrison, et al. 1993).  In CRAs performed in ablated hosts, 
varying ratios of freshly isolated Mad2+/+ or Mad2+/- C57/Bl/6 donor cells were 
mixed with freshly isolated Boy J competitor cells, and transplanted into 950 cGy 
conditioned (137Cs source, single dose) F1 recipients as described previously 
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(Campbell, et al. 2009).  Donor, competitor, and recipient peripheral blood 
chimerism was determined at 1, 2, 4, and 6 months posttransplantation.  
Peripheral blood was collected by tail-vein bleeding into heparinized 
microcapillary tubes (Fisher Scientific, Pittsburg, PA).  Red blood cells (RBCs) in 
the PB were lysed by incubating with RBC lysis buffer (0.155 M NH4Cl, 0.01 M 
KHCO3, 0.1 mM EDTA in H2O and filter sterilized) and samples were washed in 
PBS + 2% BSA.  Cells were stain with antibodies to anti-CD45.1 PE 
(phycoerythrin) and anti-CD45.2 APC (allophycocyanin) (BD-Pharmingen) and 
analyzed using a FACSCalibur with APC (Campbell, et al. 2009).  Peripheral 
blood from BoyJ, F1, and C57/Bl6 mice was used as controls.  Data analysis was 
done using FCS Express V3 software (De Novo Software, Ontario, Canada). 
 
Secondary Non-competitive Transplantation. 
Six months after the primary competitive repopulation assay was started, BM 
cells were aseptically harvested from primary F1 recipient mice, resuspended in 
IMDM, and 2 x 106 cells were injected into secondary F1 recipient mice irradiated 
with 950 cGy total body irradiation.  PB was collected from secondary animals at 
1, 2, 4, and 6 months after transplantation and analyzed for CD45.1 and CD45.2 
chimerism as described above. 
 
Statistical Analysis. 
Data were analyzed statistically using the Student’s t-test.  A P values less than 
0.05 was considered statistically significant. 
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RESULTS 
 
Nocodazole Treatment Causes Cell Cycle Arrest in HSCs. 
To evaluate whether phenotypically defined mouse HSCs function like ESCs with 
respect to checkpoint-apoptosis coupling, we first examined the ability of HSCs 
to arrest in M-phase after microtubule disruption.  Low-density mononuclear cells 
isolated from murine bone marrow were cultured in the cytokine cocktail of TPO, 
Flt3, and SCF for 24 hours before addition of nocodazole used to activate the 
SAC, in order to promote cycling in the normally quiescent HSC population.  
Leukocytes and platelets are the main constituents of the LDMC population from 
the BM, but this population also contains HPC and HSC.  Cells were incubated 
for 48 hours after nocodazole treatment, then stained and analyzed by flow 
cytometry.  Within the mononuclear fraction of cells, DNA content and levels of 
phospho-histone H3 were examined in Sca-1+/c-kit+/lin- (LSK) cells.  Phospho-
histone H3 is tightly correlated with chromosome condensation during mitosis 
and therefore serves as a marker for mitosis (Gunsilius, et al. 2001).  HSCs 
accumulated in M-phase of the cell cycle after microtubule disruption with 
nocodazole treatment (Figure 5A).  This arrest is evident by the increase of 
phosphorylation at histone H3.  This population of cells with higher levels of 
phospho-histone H3 also appears to have 4C DNA content, also indicative of cell 
cycle arrest in M-phase (Figure 5B). 
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Figure 5.  HSCs Arrest in M-phase After Nocodazole Treatment. 
(A) Murine low-density mononuclear cells (LDMCs) were treated with nocodazole 
for microtubule depolymerization or control solvent for 48 hours in media 
containing RPMI + 10% FBS + 100 ng/ml each of TPO, Flt3, and SCF as 
described in “Materials and Methods” after a 24 hour incubation in media and 
cytokines alone.  Cells were harvested and analyzed by multivariate 
permeablized flow cytometry for simultaneous phospho-histone (ser10) H3 and 
DNA content.  Results for phospho-histone H3 and DNA content are those gated 
on the Sca-1+/c-kit+/lin- (LSK) population of cells.  The circular regions indicate 
the cells that are in M-phase, as indicated by high levels of phospho-histone H3 
and 4C DNA content (N=3).  (B) Percentage of cells in M-phase as indicated by 
cells with 4C DNA content (N=3).  Data were analyzed using the Student’s t-test. 
*p < 0.05.   
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Phenotypically Defined HSCs Initiate Apoptosis After SAC Activation. 
To further examine if HSCs function like ESCs with respect to checkpoint-
apoptosis coupling, we investigated apoptotic responses in HSCs after SAC 
activation.  Upon visual inspection, fewer nocodazole treated cells were observed 
when compared to the control non-treated cells although equal numbers of cells 
were initially present in both groups.  However, the percentage of LSK cells 
present in the control and nocodazole treated population after culturing LDMC for 
the specified period of time was not significantly different, indicating that the 
percentage of LSK cells present was not altered by the presence of nocodazole.  
After SAC activation via nocodazole treatment, increased levels of activated 
caspase 3 (Figure 6A, B) and an increase in hypodiploidy (Figure 6C) were 
observed in the treated phenotypically defined HSCs compared to untreated 
HSCs.  Caspase 3 is a crucial executioner of apoptosis; it is either partially or 
entirely responsible for the proteolytic cleavage of many key proteins, such as 
the nuclear enzyme poly (ADP-ribose) polymerase (PARP) (Fernandes-Alnemri, 
et al. 1994).  Increased levels of activated caspase 3 are indicative of apoptosis 
activation in this population of cells.  These data suggest that HSC can efficiently 
initiate apoptosis after activation of the SAC, indicating that checkpoint activation 
is coupled with apoptosis in this population of cells.   
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Figure 6.  After Arresting in M-phase, HSCs Initiate Apoptosis. 
Murine LDMC were treated as in Figure 5A and analyzed by flow cytometry for 
activated caspase 3 and DNA content.  Results for activated caspase 3 and DNA 
content are those gated on the Sca-1+/c-kit+/lin- (LSK) population of cells within 
murine LDMC.  (A) Representative dot plots from flow cytometric analysis show 
elevated levels of activated caspase 3 and DNA content.  (B) The percentage of 
apoptotic cells is indicated by cells with elevated levels of activated caspase 3 
(N=3).  (C) Cells treated with nocodazole exhibit high levels of sub-G1 DNA 
content when compared to control cells, which is indicative of apoptosis.  Data 
was analyzed using the Student’s t-test.  *p<0.05.
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SAC Activation Results in Mitotic Arrest and Apoptosis in Phenotypically 
Defined HSCs From Both Mad2+/+ and Mad2+/- Mice. 
After determining that the SAC is functional in HSCs, we next examined if Mad2 
haploinsufficiency affected the ability of phenotypically defined HSCs to arrest in 
mitosis compared to wild-type HSCs.  Low-density mononuclear cells from 
Mad2+/+ and Mad2+/- mice were collected and treated with nocodazole, as 
described in the previous section.  Within the mononuclear fraction of cells, DNA 
content and levels of phospho-histone H3 were examined in LSK cells.  LSK cells 
from both Mad2+/+ and Mad2+/- mice exhibited a significant increase in phospho-
histone H3 levels, indicating that these cells arrest in M-phase of the cell cycle 
after nocodazole treatment for 24 hours (Figure 7A).  Along with the arrest in M-
phase, we noted that the 24 hour nocodazole treated Mad2+/+ and Mad2+/- LSK 
cells have significantly increased levels of sub-G1 DNA content when compared 
to the control treated cells (Figure 7B).  No significant differences existed 
between the 24 and 48 hour treatment time points for each group examined, and 
also no differences were found between Mad2+/+ and Mad2+/- control or 
nocodazole-treated groups.  These data are in agreement with data examining 
mitotic arrest in cells from Mad2+/+, Mad2+/-, and Mad2-/- embryos in response to 
spindle disruption (Dobles, et al. 2000).  Cells from Mad2-/- embryos failed to 
arrest in mitosis, but cells from Mad2+/+ and Mad2+/- embryos exhibited similar 
levels of mitotic arrest in response to nocodazole treatment (Dobles, et al. 2000). 
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Figure 7 
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Figure 7.  Mad2+/+ and Mad2+/- HSCs Arrest in M-phase After Nocodazole 
Treatment. 
Low-density mononuclear cells from the BM of wild-type Mad2+/+ and Mad2+/- 
mice were treated with nocodazole for microtubule depolymerization or control 
solvent for 24 or 48 hours in media containing RPMI + 10% FBS + 100 ng/ml 
each of TPO, Flt3, and SCF.  Cells were harvested and analyzed by multivariate 
permeablized flow cytometry for phospho-histone (ser10) H3.  Results for 
phospho-histone H3 are those gated on LSK population of cells.  (A) Percentage 
of cells in M-phase as indicated by cells with 4C DNA content and increased 
phospho-histone H3 levels (N=3).  (B) Both Mad2+/+ and Mad2+/- cells treated 
with nocodazole exhibit higher levels of sub-G1 DNA content when compared to 
untreated cells, which is indicative of apoptosis (N=3).  Data were analyzed using 
the Student’s t-test.  *p < 0.05 when comparing control to nocodazole treatment 
Mad2+/+ and Mad2+/- HSC. 
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Aged Mad2+/- Mice Exhibit Characteristics of a Myeloproliferative-like 
Disorder. 
Previous studies noted that Mad2+/- mice develop normally, and blastocysts from 
Mad2+/- animals display no evidence of an impaired checkpoint activation, but 
premature sister-chromatid separation was not examined in these experiments 
(Dobles, et al. 2000).  Subsequent studies found increased levels of premature 
sister-chromatid separation, as well as increase in aneuploidy, in Mad2+/- human 
cancer cells and primary murine embryonic fibroblasts when compared to wild-
type (Michel, et al. 2001).  Importantly, a high frequency of papillary lung 
adenocarcinomas, an extremely rare tumor in most wild-type mouse strains, is 
found in Mad2+/- mice killed between 18 and 19 months of age, suggesting a role 
for defects in the mitotic checkpoint in tumorigenesis (Tuveson and Jacks 1999).  
Defects in the mitotic checkpoint have been identified in colon, lung, and breast 
cancer cell lines (Li and Benezra 1996).  While MAD2 mutations have not been 
identified in cancer cell lines with mitotic checkpoint defects (Cahill, et al. 1999; 
Takahashi, et al. 1999), subtle differences in MAD2 protein levels appear to be 
sufficient to markedly alter checkpoint function (Michel, et al. 2001).  As a result, 
inactivation of one MAD2 allele could be enough to create a haploinsufficient 
effect and lead to loss of mitotic checkpoint control.  Therefore, we examined 
aged Mad2+/+ and Mad2+/- mice, ranging in age between 11 and 39 months old, 
to see if any irregularities existed.  The mice were dissected, and various organs 
were examined for the presence of abnormalities.  Several of the Mad2+/- mice 
examined exhibited marked hepatomegaly (Figure 8A, B), and in most instances 
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splenomegaly was also observed.  Some of these mice also had large masses in 
their lower abdomens, possibly originating from the small intestine.  All 
observations in aged Mad2+/+ and Mad2+/- mice are listed in Table 2.  Organs 
from aged Mad2+/+ (1 out of 4) and Mad2+/- (8 out of 11) mice exhibited an 
extremely high infiltration of hematopoietic cells, which is characteristic of a 
myeloproliferative disorder (MPD); representative slides of liver sections with 
H&E staining are shown in Figure 8C.  MPD is characterized by the clonal 
proliferation of one or more hematopoietic cell lineages, predominantly in the 
bone marrow, but sometimes in the liver and spleen (Talarico 1998).  A more 
complete analysis of these mice would be required in order to definitively 
diagnose them with MPD, including examination of multiple organs, particularly 
the bone marrow, as well as having age matched controls. 
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Figure 8.  Aged Mad2+/- Mice Exhibit Characteristics of Myeloproliferative 
Disorder.   
(A, B) The mice were dissected, and organs were examined for the presence of 
abnormalities.  Representative mice with liver abnormalities, along with wild-type 
mice are shown.  (C) Frozen sections were prepared and stained with H&E to 
show extramedullary hematopoiesis in spleen, liver, or other sites.  
Representative slides from liver sections are shown. 
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Table 2.  Observations in Aged Mad2+/- and Mad2+/+ Mice. 
Shown are the strain, age, sex, and abnormalities observed in aged Mad2+/- and 
Mad2+/+ mice.  All mice examined were on a mixed strain background.
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Mad2 Haploinsufficiency Protects HPC From the Cytotoxic Effects of Cell-
Cycle Specific Chemotherapeutic Agents. 
Because of the importance of Mad2 in mitosis, we hypothesized that the 
hematopoietic system of Mad2+/- mice might be more sensitive than Mad2+/+ mice 
to the cytotoxic effects of irradiation and chemotherapeutic agents.  We therefore 
evaluated the in vivo cytotoxic effects of irradiation and chemotherapeutic agents 
on BM HPC from Mad2+/+ and Mad2+/- mice.  Mice were treated with either 
cyclophosphamide (200 mg/kg, i.p.), a high sub-lethal dose (650 cGy) of γ-
radiation, or cytarabine (Ara-C) (500 mg/kg, s.c.) and then assessed for recovery 
of the HPC, expressed as absolute numbers per femur.  The recovery of HPC 
was evaluated through examination of colony-forming ability at lowered (5%) 
oxygen (O2) tension.  Lowered O2 tension much more closely mimics the O2 
tension in bone marrow, and is more physiological.  Bone marrow HPC colonies 
grow better at 5% O2 tension compared to colonies grown at 20% O2 tension 
(Bradley, et al. 1978).  Hence the reason all of our studies assessing HPC were 
done at 5% O2 tension, unless stated otherwise.  No significant differences were 
observed in the recovery of functional BM or spleen HPC after treatment with 
cyclophosphamide (Figure 9A, B) or γ-radiation (Figure 10A, B); however, we 
found that Mad2 haploinsufficiency protected the BM HPCs from the cytotoxic 
affects of Ara-C (Figure 11).  The number of Mad2+/- HPCs, in contrast to the 
number of Mad2+/+ littermate control HPCs, does not decrease during the nadir 
period of recovery from Ara-C treatment, and thus these cells appear to be 
protected from the cytotoxic effects of Ara-C.  Thus, our studies have 
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unexpectedly found that Mad2 haploinsufficiency does not render the 
hematopoietic system more susceptible than control mice to the suppressive 
effects of cytotoxic treatment. 
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Figure 9.  No Difference in the Recovery of Mad2+/+ and Mad2+/- BM and Spl 
HPC After Cyclophosphamide Treatment. 
Bone marrow (A) and spleen (B) cells collected from Mad2+/+ and Mad2+/- mice 
treated with cyclophosphamide (200 mg/kg, i.p.) were assessed for total 
progenitor cells (stimulated in vitro with Epo, PWMSCM, and SCF) at days 0, 1, 
3, 5, and 7 after treatment.  In short, for the methylcellulose assay, 5 x 104 cells 
were plated and cultured in 0.9% methylcellulose culture medium with 30% FBS, 
5% vol/vol PWMSCM, 50 ng/mL rmuSCF, 1 U/mL rhuEpo, 2 mM glutamine, 10-4 
M 2-mercaptoethanol, and 0.1 mM hemin.  Colonies were scored after 7 days of 
incubation at 37ºC, in 5% O2 and 5% CO2.  Absolute numbers of progenitors 
were calculated from the nucleated cellularity per femur and the number of 
colonies formed per number of cells plated.  Five mice of each genotype were 
used for each time point (N=1). 
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Figure 10.  No Difference in the Recovery of Mad2+/+ and Mad2+/- BM and Spl 
HPC After Treatment with γ-Irradiation.   
Bone marrow (A) and spleen (B) cells collected from Mad2+/+ and Mad2+/- mice 
treated with sub-lethal dose of γ-irradiation (650 cGy) were assessed for total 
progenitor cells (stimulated in vitro with Epo, PWMSCM, and SCF) at days 0, 7, 
10, and 14 after treatment.  In short, for the methylcellulose assay, 5 x 104 cells 
were plated and cultured in 0.9% methylcellulose culture medium with 30% FBS, 
5% vol/vol PWMSCM, 50 ng/mL rmuSCF, 1 U/mL rhuEpo, 2 mM glutamine, 10-4 
M 2-mercaptoethanol, and 0.1 mM hemin.  Colonies were scored after 7 days of 
incubation at 37ºC, in 5% O2 and 5% CO2.  Absolute numbers of progenitors 
were calculated from the nucleated cellularity per femur and the number of 
colonies formed per number of cells plated.  Five mice of each genotype were 
used for each time point (N=1). 
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Figure 11.  Mad2+/- BM Cells, Unlike Mad2+/+ BM Cells, are Protected From 
the Cytotoxic Effects of Ara-C. 
Bone marrow cells collected from Mad2+/+ and Mad2+/- mice treated with Ara-C 
(500 mg/kg, s.c.) were assessed for total progenitor cells (stimulated in vitro with 
Epo, PWMSCM, and SCF) at days 0, 1, 3, and 5 after treatment.  In short, for the 
methylcellulose assay, 5 x 104 cells were plated and cultured in 0.9% 
methylcellulose culture medium with 30% FBS, 5% vol/vol PWMSCM, 50 ng/mL 
rmuSCF, 1 U/mL rhuEpo, 2 mM glutamine, 10-4 M 2-mercaptoethanol, and 0.1 
mM hemin.  Colonies were scored after 7 days of incubation at 37ºC, in 5% O2 
and 5% CO2.  Absolute numbers of progenitors were calculated from the 
nucleated cellularity per femur and the number of colonies formed per number of 
cells plated.  Five mice of each genotype were used for each time point (N=1).  
*p<0.05 in comparison to day 0 untreated control. 
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Decreases in Progenitor Numbers and Cycling Status are Observed in BM 
HPC From Mad2+/- mice. 
We had previously reported that Mad2+/- BM HPCs were in a slow or non-cycling 
state and the absolute numbers of these progenitors were decreased in 
comparison to Mad2+/+ BM.  This could potentially protect Mad2+/- HPC after in 
vivo treatment of mice with Ara-C.  The mice used in our previously published 
studies (Ito, et al. 2007) were on a mixed background; however, the mice used in 
the present studies were on a C57Bl/6 background.  To determine if functional 
differences are present in the Mad2+/- and Mad2+/+ HPC from mice on a C57Bl/6 
background, we set up clonogenic progenitor assays to assess absolute 
numbers and cycling status.  As shown in Figure 12A, significantly decreased 
numbers of immature progenitors, CFU-GEMM, CFU-GM, and BFU-E 
(responsive to stimulation by multiple growth factors) were observed in Mad2+/- 
BM compared with Mad2+/+ BM.  Using the high-specific activity tritiated 
thymidine kill assay to analyze the cell-cycling status of progenitors, we found 
that the percentage of immature progenitor cells in the S-phase of the cell cycle 
was significantly decreased in Mad2+/- BM (Figure 12B).  These results are in 
agreement with previous findings (Ito, et al. 2007), demonstrating that Mad2 
plays a role in HPC proliferation in mice on a C57Bl/6 background.  However, 
these changes in numbers of immature progenitors subsets of progenitors did not 
translate into changes in blood counts or in cellularity of BM and spleen between 
Mad2+/- and Mad2+/+ mice (Ito, et al. 2007). 
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Figure 12 
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Figure 12.  Functional Analysis of BM HPC From Untreated Mice 
Demonstrates Decreased Numbers and Cycling of Mad2+/- HPC.   
Bone marrow from Mad2+/+ and Mad2+/- mice was assessed for (A) absolute 
numbers of immature progenitor cells and (B) the percentage of these BM 
progenitors in S-phase.  In short, for the methylcellulose assay, 5 x 104 cells 
were plated and cultured in 0.9% methylcellulose culture medium with the 
combination of 30% FBS, 5% vol/vol PWMSCM, 50 ng/mL rmuSCF, 1 U/mL 
rhuEpo, 2 mM glutamine, 10-4 M 2-mercaptoethanol, and 0.1 mM hemin.  
Colonies were scored after 7 days of incubation at 37ºC, in 5% O2 and 5% CO2.  
Absolute numbers of progenitors were calculated from the nucleated cellularity 
per femur and the number of colonies formed per number of cells plated (N=3; 3 
mice of each genotype were used for each experiment).  *p<0.05. 
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Phenotypic Characterization of HSC and HPC Populations in Mad2+/- and 
Mad2+/+ Mice. 
To further characterize the HSC and HPC populations in the BM, we did a 
phenotypic analysis of these cell populations.  The markers used to define each 
population and the gating strategy used for flow cytometry are shown in Figure 
13A, and a representative dot plot using this gating strategy to analyze mouse 
BM is shown in Figure 13B.  Examination of the LSK cells revealed no significant 
differences in this population in the Mad2+/- and Mad2+/+ mice.  We examined the 
CLP, MEP, and GMP populations in both types of mice, and also found that no 
significant differences exist in these populations in both mice.  We did find that 
the absolute numbers of CMP were slightly, but significantly increased in the 
Mad2+/- mice (Figure 13C).  The fact that the numbers of phenotyped populations 
of CMP and GMP were respectively slightly increased or not different in Mad2+/- 
and Mad2+/+ mice, yet there were significant decreases in the numbers and 
cycling status of Mad2+/- CFU-GM, BFU-E, and CFU-GEMM suggests that 
phenotypes of cells in this case do not provide telling information about the 
functional proliferative capacity of these cells after cytokine stimulation in vitro. 
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Figure 13.  Phenotypic Analysis of HSC and HPC Populations Reveals No 
Changes in LSK, CLP, GMP, and MEP, But a Slight Increase in CMPs in 
Mad2+/- Mice.   
Bone marrow from Mad2+/+ and Mad2+/- mice was assessed for the number of 
phenotypically defined progenitors per femur.  (A) Bone marrow was collected 
and stained with fluorescent antibodies to various surface markers; cells were 
then analyzed by flow cytometry following the gating strategy shown.  (B) A 
representative dot plot showing the different stem and progenitor populations in 
the BM.  (C) The following stem and progenitor populations were examined: LSK 
- Lin- Sca-1+ c-kit+ IL-7Rα-; CMP (common myeloid progenitor) - Lin- Sca-1- c-kit+ 
CD34+ FcγR-/lo; GMP (granulocyte/macrophage progenitor) - Lin- Sca-1- c-kit+ 
CD34+ FcγR+/hi; MEP (megakaryocyte/erythroid progenitor) - Lin- Sca-1- c-kit+ 
CD34- FcγR-/lo; CLP (common lymphoid progenitor) - Lin- Sca-1+ c-kit+ IL-7Rα+.  
Results shown are the average of 3 independent experiments using 3 mice of 
each genotype per experiment.  *p<0.01.
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Mad2 Haploinsufficiency Does Not Affect the Long-Term Repopulating 
Ability of HSC. 
The discrepancy between phenotype and function of Mad2+/- HPCs made it clear 
that a functional assessment of Mad2+/- HSC was necessary.  In order to 
determine if Mad2 haploinsufficiency affects the function of HSC, we performed 
competitive repopulations assays (CRA) to examine the short- and long-term 
repopulating ability of Mad2+/- HSC compared to Mad2+/+ HSC.  Various 
concentrations of freshly isolated Mad2+/+ or Mad2+/- Bl/6 BM (CD45.2 donor) 
cells were mixed with 1 x 105 freshly isolated Boy J BM (CD45.1 competitor) 
cells, and these mixtures were transplanted into the 950 cGy-conditioned F1 
(CD45.1/CD45.2) recipients (Figure 14A).  Peripheral blood donor cell chimerism 
was determined at 1, 2, 4, and 6 months posttransplant.  Representative flow 
cytometry analyses from controls and recipients at 4 months posttransplant are 
shown in Figure 14B.  The percentages in each quadrant indicate the percentage 
of the population that expresses either CD45.1 (PE single positive) or CD45.2 
(APC single positive) or for both CD45.1 and CD45.2 (PE/APC double positive).  
The left panel shows the relative engraftment of fresh Mad2+/+ donor cells, 
competitor cells, and residual recipient cells.  In the right panel, recipients were 
transplanted with a mixture of competitor cells and Mad2+/- donor cells.  The 
composite data for the donor cell chimerism (CD45.2) from the complete 
experiment is shown in Figure 14C.  For the various different donor to competitor 
ratios used, no significant difference in the percent CD45.2 chimerism in the  
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peripheral blood was observed between Mad2+/+ or Mad2+/- cells.  This indicates 
that Mad2 haploinsufficiency does not affect the ability of HSC to engraft and 
compete in a transplant setting. 
 
After 6 month posttransplant, the recipient F1 mice were sacrificed and BM was 
collected to perform a secondary non-competitive transplant into new 950 cGy-
conditioned F1 recipients.  Peripheral blood donor cell chimerism was 
determined at 1, 2, 4, and 6 months posttransplant.  Data from the secondary 
transplant shows no consistent significant difference in the percent peripheral 
blood chimerism between Mad2+/+ or Mad2+/- cells (Figure 14D).  This suggests 
that Mad2 haploinsufficiency does not affect either engrafting capability, numbers 
of functional HSC, or self-renewal of HSCs. 
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Figure 14.  Mad2 Haploinsufficiency Does Not Affect the Long-Term 
Repopulating Ability of HSC Compared to Wild-Type HSC.   
(A) Donor (CD45.2) and competitor (CD45.1) BM cells were transplanted into a 
lethally irradiated recipient (CD45.1/45.2) mice at the ratios indicated.  (B) 
Representative flow cytometry analyses from the recipients of either Mad2+/+ or 
Mad2+/- donor cells 6 months post-transplant are shown along with controls.  
Peripheral blood (PB) was collected at months 1, 2, 4, and 6 after primary 
transplant (C); 6 months after the primary transplants, secondary transplants 
were performed and PB was collected at months 1, 2, 4, and 6 (D).  Primary 
transplant data represents 3 separate experiments using 5 mice per transplant 
group.  Secondary transplant data represents 2 separate experiments using 5 
mice per transplant group.  Data were analyzed using the Student’s t-test.  
*p<0.05.
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Mad2+/- BM HPCs are Less Sensitive to the Cytostatic Effects Caused by 
Blocking the Redox Function of Ape1/Ref-1 and Do Not Respond Well to 
the Effects of Lowered O2 Tension. 
After finding that functional differences exist between Mad2+/- and Mad2+/+ HPC, 
but not HSC, we decided to further examine HPC function in these mice.  To 
examine how Mad2+/- BM HPCs respond to cytostatic effects of drugs in 
comparison to Mad2+/+ HPC, we treated these cells with E3330.  E3330 is a 
highly specific inhibitor of Ape1/Ref-1 (APE1) redox activity.  It has been shown 
that E3330 does not increase the percentage of cells undergoing apoptosis, but 
rather stops them from proliferating (Fishel, et al. 2010; Luo, et al. 2008).  APE1 
is a multifunctional protein involved in both the base excision repair pathway and 
redox regulation of various transcription factors, including AP-1, HIF-1α, and p53 
(Jayaraman, et al. 1997; Lando, et al. 2000; Xanthoudakis, et al. 1992).  A 
previous study showed that the redox function, but not the DNA repair activity of 
APE1 is required for normal embryonic hematopoiesis (Zou, et al. 2007).  
However, the function of this protein has not been thoroughly invested in normal 
adult hematopoiesis.  Using E3330, we examined colony-forming ability of both 
Mad2+/+ and Mad2+/- HPC in vitro at normoxic (~20%) and at lowered (5%) 
oxygen (O2) tension.   
 
For wild-type Mad2+/+ BM HPC, E3330 has a greater effect under 5% oxygen 
tension, causing not only a decrease in colony formation under maximum 
stimulation or with single growth factors (Figure 15A, B), but also blocking 
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synergistic growth with defined growth factors (Figure 15C).  Upon examination 
of colony formation from Mad2+/- HPC with the lowest concentration of E3330 
used, we found no significant differences in colony formation between E3330 and 
vehicle control treated cells, while wild-type HPC colony formation was 
significantly inhibited.  The percent decrease compared to DMSO control is 
significantly greater in the wild-type cells compared to Mad2+/- cells (Figure 15D-
F).  This is true at both 5% and 20% O2 tension, and interestingly, Mad2+/- HPC 
do not grow better at lower O2 tension as do wild-type HPC.  However, by 
increasing the concentration of E3330 used, we were able to inhibit Mad2+/- HPC 
colony formation, but still not to the extent of Mad2+/+ HPC. 
 
To ensure the differences in inhibition were not due to inherent changes in cell 
cycle between wild-type and Mad2+/- HPC and to ensure that E3330 is not cell 
cycle specific, a high specific activity tritiated thymidine kill assay was performed 
in the presence and absence of E3330 to estimate the percentage of cells in S-
phase.  The percentage of wild-type cells in S-phase is similar in the presence 
and the absence of E3330 (Figure 15G) and the same is true for Mad2+/- HPC; 
this indicates the inhibitor is not cell cycle specific.  The inhibition of Mad2+/- HPC 
colony formation only under higher concentrations of E3330 suggests that 
Mad2+/- HPC are less sensitive to the cytostatic effects of the inhibitor compared 
to Mad2+/+ HPC. 
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Figure 15.  Mad2+/- BM Cells are Less Sensitive to the Cytostatic Effects 
Caused by Blocking the Redox Function of Ape1/Ref-1 Compared to 
Mad2+/+ BM Cells.  
Bone marrow cells collected from Mad2+/+ and Mad2+/- mice were treated with 
various concentrations, ranging from 12.5 µM to 25 µM, of E3330 or DMSO 
control for 4 hours before placing cells into colony assays.  (A) Cells plated in the 
presence of Epo, PWMSCM, and SCF; (B) cells plated with GM-CSF; (C) cell 
plated with GM-CSF and SCF.  (D, E, F) The percent DMSO control in the 
presence of E3330 for the same conditions used in A, B, and C, respectively.  
(G) The percentage of these BM progenitors in S-phase as estimated by 
thymidine kill.  Colonies were scored after 7 days of incubation at 37ºC, in 5% O2 
and 5% CO2 or 20% O2 and 5% CO2 (at least 3 mice of each genotype were 
used in these experiments).  Data were analyzed using the Student’s t-test.  A P 
value less than 0.05 was considered statistically significant.  N ≥ 3 *p<0.05, 
†p<0.01, ‡p<0.001 compared to DMSO control. 
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DISCUSSION 
 
We demonstrate that phenotypically defined HSCs show an arrest in the M-
phase of the cell cycle in response to treatment with nocodazole, a microtubule-
depolymerizing agent.  This arrest, shown by an increase in phospho-histone H3 
in nocodazole treated cells, implies that the SAC is functional in this population of 
cells.  Also in response to nocodazole, HSCs initiate apoptosis, evident by 
increased levels of activated caspase 3, subdiploid levels of DNA, and decreases 
in cell number.  These data lead to the conclusion that HSCs exhibit coupling of 
apoptosis to activation of the SAC, a condition observed in somatic cells.  This is 
in contrast to ESCs, which accumulate in M-phase after nocodazole treatment, 
but then exit this mitotic delay and re-enter a polyploid mitosis.  We also 
conclude that HSCs do not function like embryonic stem cells, which exhibit 
uncoupling of apoptosis from checkpoint activation and tolerance to 
tetraploidy/aneuploidy (Mantel, et al. 2007).  
 
The efficiency of the SAC is particularly important in HSCs, since these cells give 
rise to many different types of progenitor cells populations, including the myeloid 
and lymphoid lineages of cells.  Uncoupling of SAC activation from apoptosis 
could lead to chromosome instability not only in HSCs themselves, but also in all 
the progenitor populations descending from these cells.  As previously described,  
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chromosome instability leading to aneuploidy characterizes many cancers 
(Bharadwaj and Yu 2004).  Therefore, chromosome instability in HSCs and their 
progenitors could lead to cancers derived from these cell types, such as 
leukemia or lymphoma. 
 
Ex vivo culture and expansion of hematopoietic stem and progenitor cells could 
prove problematic in a situation of checkpoint-apoptosis uncoupling.  In 
numerous settings, ex vivo manipulation of HSC and HPC occurs before the cells 
are used in research or clinical applications.  If these cells exhibit defects in 
checkpoints and/or apoptosis initiation as previously suggested (Damelin, et al. 
2005; Mantel, et al. 2007), cells with genomic abnormalities could accumulate 
and negatively affect the outcome of experiments or treatments.  However, the 
observation that HSCs efficiently initiate apoptosis after SAC activation indicates 
these cells will undergo programmed cell death if problems arise during mitosis, 
lessening concerns that the stress of ex vivo expansion of HSCs could cause 
instability in HSCs that might lead to disordered growth and survival after 
transplantation of the expanded cells. 
 
After exposing BM low-density mononuclear cells (LDMCs) from Mad2+/+ and 
Mad2+/- mice to nocodazole for either 24 or 48 hours, both cells types arrest in M-
phase and subsequently initiate apoptosis.  These results are similar to 
observations in cells from Mad2+/- embryos; cells from Mad2-/- embryos failed to 
arrest in mitosis, but cells from Mad2+/+ and Mad2+/- embryos exhibited similar 
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levels of mitotic arrest in response to nocodazole treatment (Dobles, et al. 2000).  
After exposure to nocodazole for over 48 hours, Hct-MAD2+/- cells (generated 
from Hct-116 human colon carcinoma cell line) become multinucleated with a 
polyploid DNA content; the checkpoint status of ten independent subclones 
derived from the Hct-116 parental line was found to be normal, which excludes 
clonal variation as the cause of the checkpoint defect in Hct-MAD2+/- clones 
(Michel, et al. 2001).  Although we do not see any differences between Mad2+/+ 
and Mad2+/- HSC in the ability to arrest in M-phase after microtubule disruption, 
we have not ruled out the possibility that changes in Mad2 protein levels can lead 
to changes in ploidy.  Murine embryonic fibroblasts (MEF) derived from MAD2+/- 
mice showed high frequencies of premature sister chromatid separate after SAC 
activation, which leads to aneuploidy in these cells.  Also, we have not examined 
the levels of survivin in Mad2+/+ and Mad2+/- HSC to see if they are altered.  
Survivin is not only a member of the chromosomal passenger complex, but also 
functions as an inhibitor of apoptosis 
 
We observed marked hepatomegaly and in some instances splenomegaly in 
aged Mad2+/- mice.  Histological analysis of their livers and spleens with H&E 
staining revealed these organs exhibited an extremely high infiltration of 
hematopoietic cells, which is characteristic of a myeloproliferative disorder 
(MPD).  These observations suggest that Mad2 haploinsufficiency might 
contribute to development of an MPD-like condition after a long latency period.  
Although previous studies noted that Mad2+/- mice develop normally, and 
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blastocysts from Mad2+/- mice display no evidence of an impaired checkpoint 
activation (Dobles, et al. 2000), examination of metaphase spreads from MEFs 
derived from a Mad2+/- mouse (Dobles, et al. 2000) revealed a significant 
increase in the number of aneuploid cells relative to the controls (Michel, et al. 
2001).  Papillary lung adenocarcinomas are found in 18-19 month old Mad2+/- 
mice (Tuveson and Jacks 1999).  The long latency period essential for tumor 
formation in the Mad2+/- mice suggests that additional mutations at other 
oncogenic or tumor-suppressor loci are required for transformation in checkpoint-
defective cells.  Defects in the mitotic checkpoint have been identified in colon, 
lung and breast cancer cell lines (Li and Benezra 1996).  A defect in one allele of 
Cdc20, in which the Mad2-binding sites were mutated so that Mad2 can no 
longer inhibit the protein, renders the SAC dysfunctional (Li, et al. 2009).  Mice 
with this defect contain a high percentage of aneuploid cells and develop 
spontaneous neoplasms (13.8% were hepatomas and the rest were lymphomas) 
at an increased rate, indicating that the SAC-mediated inhibition of Cdc20 is an 
important tumor-suppressing mechanism.  Further analysis of the mutant cells 
revealed that the timing of anaphase depended on Mad2-Cdc20 interaction (Li, et 
al. 2009).  These data imply that defects in Mad2, as well as the SAC, may not 
only be a direct cause of chromosomal instability (CIN), but may also contribute 
to tumorigenesis. 
 
Control of the SAC is compromised in virtually all CIN tumors (Li and Zhang 
2009; Rajagopalan and Lengauer 2004).  The best understood aspect of CIN is 
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aneuploidy, and most carcinomas show variations in chromosome number that 
arise from the loss and gain of entire chromosomes during mitosis (Jallepalli and 
Lengauer 2001).  Aneuploidy is one of the first oncogenic events in mouse 
models of adenomatous polyposis coli (Alberici, et al. 2007), and mathematical 
models predict that aneuploidy is required for sporadic carcinogenesis (Nowak, 
et al. 2002).  Tumor cells with defects in the spindle checkpoint, such as Hct-
Mad2+/- cells, have been shown to become highly aneuploid and continue to 
cycle after prolonged exposure to spindle inhibitors (Michel, et al. 2001), 
suggesting checkpoint-defective tumors could potentially be resistant to anti-
mitotic chemotherapeutics.  Unexpectedly, Mad2, along with other proteins in the 
SAC, play a role in prolonging G2/M arrest after recognition of an unrepaired 
double-strand break in the DNA (Dotiwala, et al. 2010); this further implies the 
importance of Mad2 in the cell and demonstrates how defects in Mad2 could lead 
to tumorigenesis.  The development of an MPD-like condition in aged Mad2+/- 
mice suggests that compromised control of the SAC plays a role in the 
development of this condition.  The classification MPD includes polycythemia 
vera (PV), chronic idiopathic myelofibrosis (CIMF), essential thrombocythemia 
(ET), chronic myelogenous leukemia (CML), and chronic myelomonocytic 
leukemia (CMML) (Talarico 1998).  In some disorders, specific characteristic 
chromosomal changes are seen.  CML is characterized by a specific 
chromosomal abnormality and specific molecular abnormality; the Philadelphia 
chromosome is a reciprocal translocation between the long arms of 
chromosomes 9 and 22, which creates the fusion gene bcr/abl (Linker Charles A 
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2011).  Interestingly, down-regulation of BRCA1 has been observed in 
hematopoietic cells expressing the BCR-ABL fusion protein (Deutsch, et al. 
2003).  Recent findings showed that BRCA1, in addition to its role in DNA 
damage response, acts as an upstream regulator of genes involved in the mitotic 
checkpoint regulation, thus protecting against promotion of aberrant divisions and 
aneuploidy (Wolanin, et al. 2010).  Bcr-Abl leads to decreased expression of 
genes involved in the mitotic checkpoint activation - Mad2, Bub1, Bub3, and 
BubR1, resulting in mitosis perturbances, weakened mitotic checkpoint function, 
and mitotic slippage after nocodazole treatment (Wolanin, et al. 2010).  In the 
other subsets of MPD, however, various abnormalities or deletions of whole 
chromosomes or particular chromosome arms have been frequently observed 
(Linker Charles A).  Genetic inactivation of a single allele of human MAD2 
confers CIN on diploid cells (Michel, et al. 2001), and therefore it is plausible that 
the inactivation of a single allele of murine MAD2 could cause any of the cells in 
a Mad2+/- mouse to lose or gain whole or partial chromosomes.  These 
alterations to the genome could be one of many changes in the hematopoietic 
cells that lead to the development of a myeloproliferative-like disorder observed 
in aged Mad2+/- mice. 
 
Mad2 Haploinsufficiency Affects HPC Function, But Not HSC Function. 
Using Mad2+/- mice on a C57Bl/6 background, we found decreases in progenitor 
numbers and cycling status in BM HPC, demonstrating that the previously 
described effects of Mad2 haploinsufficiency of mice on a mixed strain 
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background on hematopoiesis (Ito, et al. 2007) were not strain dependent.  
However, our present functional data seem to be in disagreement with our 
phenotypic analysis showing that the GMP and MEP populations are not different 
and CMPs are slightly, but significantly increased in the BM of Mad2+/- mice 
compared to Mad2+/+ mice.  One explanation for this could be that although there 
are greater numbers of CMPs in Mad2+/- BM, these cells could in fact just be less 
functional than their wild-type counterparts due to decreases in Mad2 protein 
levels.  The functional differences may not be reflected in the overall 
phenotypically defined population because of the massive reserve of 
hematopoietic progenitor cells that normally exist in the BM of mice (Broxmeyer, 
et al. 2005). 
 
To examine if functional differences exist between Mad2+/- HSC compared to 
Mad2+/+ HSC, we set up a competitive repopulation assay.  The CRA defines the 
competitive nature of the HSC, and secondary repopulation studies allow for the 
measurement of self-renewal capabilities of the HSC.  We found no significant 
differences in the long-term engraftment of Mad2+/- HSC and Mad2+/+ HSC in 
either the primary or secondary transplants.  This indicates that Mad2 
haploinsufficiency does not have a negative effect on the ability of the HSC to 
compete, engraft, or self-renew.  This may not be too surprising considering that 
Mad2-/- embryos appear normal in utero and in culture until embryonic day E5.5 
while Mad2-/- embryos die in utero about 6.5-7.5 days after conception (E6.5-
E7.5) (Dobles, et al. 2000).  Subtle differences in morbidity rates occur between 
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the colonies of Mad2+/+ and Mad2+/- mice, but overall the Mad2+/- animals appear 
largely normal (Dobles, et al. 2000).  Also, Mad2+/+ and Mad2+/- SL (Sca-1+, lin -) 
cells have been found to express similar levels of CXCR4, and both Mad2+/+ and 
Mad2+/- BM HPC migrate toward SDF-1 in a chemotaxis assay (Broxmeyer, et al. 
2007).  Since these studies were done in BM HPC, it does not necessarily mean 
these results will carry over into HSC.  However, since we do not observe 
significant differences in the competitive repopulating ability of Mad2+/+ and 
Mad2+/- HSC, these chemotaxis assays may provide an accurate estimation of 
the ability of Mad2+/+ and Mad2+/- HSC to home to the BM microenvironment.  
Another possible reason why we observe no difference in the competitive 
repopulating ability of Mad2+/+ and Mad2+/- HSC is that the high turnover rate of 
mature hematopoietic cells might prevent us from observing any significant 
differences.  Although we are ultimately examining HSC function, we examine 
the PB for percentage of hematopoietic cells from our donor populations to 
gauge what is happening in the BM.  While this is method normally reflects what 
is occurring in the HSC population, it might not be in the case for Mad2+/- HSC.  It 
is also possible that even at the lowest donor to competitor ratio used, the BM 
compartment is at capacity due to the fact that both donor and competitor HSC 
and HPC are transplanted into the recipient, which might still retain a small 
portion of its own hematopoietic compartment despite lethal irradiation.  Since we 
do not see significant differences in competitive repopulating ability, using an 
even lower number of donor and competitor cells, doing quaternary or tertiary 
transplants, or even performing a non-competitive repopulation assay might allow 
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differences to be detected if they truly do exist.  Much like the observance that 
papillary lung adenocarcinomas are found only in aged Mad2+/- mice (Tuveson 
and Jacks 1999), Mad2+/- HSC might also require this long latency period to 
exhibit differences in repopulating ability compared to Mad2+/+ HSC. 
 
Previous studies in our laboratory found a higher percentage of cell death in KL 
(c-kit+, lin-) BM of Mad2+/- mice compared Mad2+/+ BM when cells were cultured 
in SCF and GM-CSF (Ito, et al. 2007).  However, there was no significant 
difference between Mad2+/- and Mad2+/+ mice in the percentage of cell death of 
BM cells before cell culture, suggesting that greater cell death may occur in 
Mad2+/- HPC in stress conditions but not in steady state conditions (Ito, et al. 
2007).  To examine this, we exposed Mad2+/- and Mad2+/+ mice to various 
cytotoxic and cytostatic agents.  No significant differences were observed in the 
recovery of functional BM or spleen HPC from Mad2+/- and Mad2+/+ mice after 
treatment with cyclophosphamide or γ-irradiation.  In contrast, we found that 
Mad2+/- HPCs were not affected by the cytotoxic affects of Ara-C even though 
Mad2+/+ HPCs were.  In fact, Mad2 haploinsufficiency may be somewhat 
myeloprotective to a cell cycle specific chemotherapy.  The decreased 
percentage of cycling Mad2+/- HPCs compared to Mad2+/+ HPCs might in part 
account for the differences observed in the recovery of HPCs from treatment with 
Ara-C, which selectively inhibits DNA synthesis, mainly affecting rapidly dividing 
cells.  The differences might also be due to the increased absolute numbers of 
CMP observed in Mad2+/- mice.  Even though the Mad2+/- HPCs did not appear 
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to be protected from the effects of treatment with cyclophosphamide or γ-
irradiation, they recovered in a similar manner to Mad2+/+ HPC, indicating that 
they are not any more sensitive to these cytotoxic treatments than the Mad2+/+ 
HPC.  
 
After finding that functional differences exist in the BM HPC populations of 
Mad2+/+ and Mad2+/- mice, we examined how these populations responded to 
blocking the redox function of APE1.  It has previously been shown that E3330 
stops cells from proliferating (Fishel, et al. 2010; Luo, et al. 2008); it does not 
increase the percentage of cells undergoing apoptosis.  APE1 is a transcriptional 
regulator of gene expression by acting as a redox co-activator of many 
transcription factors (Huang and Adamson 1993; Jayaraman, et al. 1997; Lando, 
et al. 2000; Xanthoudakis, et al. 1992).  Although the precise molecular 
mechanisms for APE1’s vital role in mammalian cells is still not fully understood, 
data indicates that the redox function is crucial for cell growth (Vascotto, et al. 
2009).  When examining the cytostatic effects of E3330, the drug appears to 
have a greater effect in 5% O2 tension than in 20% O2 tension.  At 5% O2, we 
observed a significant decrease in colony formation of Mad2+/+ HPC under 
maximum stimulation and also blocking of synergistic growth with defined growth 
factors in the presence of the lowest concentration of E3330.  Significant 
changes were not observed under 20% O2.  These data suggest that the redox 
function of APE1 is important in normal adult hematopoiesis, particularly under 
lower oxygen tension.  This may also suggest the transcription factors that are 
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normally upregulated under hypoxic conditions may be important for colony 
formation and growth.  The growth inhibitory effects of E3330 have been shown 
to be accentuated by hypoxia in pancreatic cancer cells (Zou and Maitra 2008), 
also suggesting an enhance requirement for APE1 redox function in hypoxia. 
 
When comparing colonies from Mad2+/- HPC to wild-type HPC colonies, we 
found no significant differences in colony formation between E3330 and vehicle 
control treated Mad2+/- cells with lower concentrations of E3330.  In contrast, 
wild-type HPC colony formation was significantly inhibited using the same E3330 
concentration.  The percent decrease compared to DMSO control is always 
greater in the wild-type cells compared to Mad2+/- cells under either oxygen 
tension.  Also, Mad2+/- HPCs do not grow better at lower O2 tension as do wild-
type HPC.  We observed similar colony numbers formed from Mad2+/- HPCs with 
mixed growth factors at 5% and 20% O2 tension.  This has never been shown 
before with Mad2+/- HPC colony formation; earlier studies in our laboratory only 
examined Mad2+/- HPC growth under 5% O2 tension (Ito, et al. 2007). 
However, when higher concentrations of E3330 were used, Mad2+/- HPC colony 
formation was inhibited, but not to the same extent as wild-type Mad2+/+ HPC.  
Inhibition of Mad2+/- HPC colony formation only under higher concentrations of 
E3330, along with the lack of inhibition of Mad2+/- HPC by low concentrations of 
E3330, suggests that Mad2+/- HPC are less sensitive to the cytostatic effects of 
the inhibitor compared to Mad2+/+ HPC.  Initially we thought that the differences 
between Mad2+/- HPC and Mad2+/+ HPC colony formation in the presence of 
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E3330 might be due to inherent differences in the cycling status of the 
progenitors.  We found the percentage of wild-type HPC in S-phase is similar in 
the presence and the absence of E3330; the same is true for Mad2+/- HPC.  This 
indicates the inhibitor is not cell cycle specific and therefore the cycle status of 
Mad2+/- HPC cannot account for the differences in sensitivity of E3330 observed 
in Mad2+/- and Mad2+/+ HPC.  However, a study in mouse ES cells and ES cell-
derived embryoid body (EB) cells revealed that siRNA knockdown of APE1 
expression induced a G1 arrest and decreased the percent of cells in S-phase, 
indicating APE1 regulates cell-cycle status in ES cells and also positively 
regulates the G1/S transition of the cell cycle in EB cells (Zou, et al. 2007).  It is 
possible that Mad2+/- HPC are less sensitive the effects of E3330 because they 
already exhibit cell cycle defects.  However, knockdown of APE1 removes not 
only its redox signaling function, but also its DNA repair function, along with 
protein-protein interactions with other DNA repair and other proteins independent 
of the redox or DNA repair functions.  Therefore, inhibition of APE1 redox 
function with the small molecule inhibitor E3330 is not directly comparable to 
siRNA knockdown studies. 
 
In conclusion, the data presented in this study provides evidence that the SAC is 
functional in phenotypically defined HSCs, and treatment with a microtubule-
destabilizing agent results in no differences in mitotic arrest and apoptosis in 
Mad2+/- and Mad2+/+ HSCs.  It also suggests that Mad2 haploinsufficiency affects 
the function of HPCs, but not the HSC population.  Although Mad2+/- HPCs have 
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decreased colony numbers and cycling status compared to Mad2+/+ HPCs, they 
appear to be protected from cytotoxic effects in vivo of a cell-cycle specific agent, 
as well as the cytostatic effects of an APE1 inhibitor.  We also found that the 
redox function of APE1 positively regulates adult hematopoiesis, and control of 
the cell cycle also appears to be important in this regulation process, events 
associated with HPC growing at lowered O2 tension.  These data, along with 
previously published data (Ito, et al. 2007), would suggest that Mad2 
haploinsufficiency alters the function of functional HPC due to changes in 
signaling.  However, the exact signaling pathways altered in Mad2+/- HPC need 
to be determined in order to fully understand the role Mad2 plays in 
hematopoiesis. 
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FUTURE DIRECTIONS 
 
Although we observed no differences in the ability of Mad2+/+ and Mad2+/- 
phenotypically defined HSC to arrest in M-phase and initiate apoptosis after 
nocodazole treatment, we did not determine whether premature sister chromatid 
separation occurred in these experiments.  Previously published data found that 
Mad2+/- MEF cultures exhibited high frequencies of premature sister chromatid 
separation in the presence of colcemid, a spindle inhibitor, along with increases 
in the overall number of aneuploid cells (Michel, et al. 2001).  To determine if this 
occurs in Mad2+/- HSC, we would examine metaphase spreads from both 
Mad2+/+ and Mad2+/- HSCs after treatment with a spindle inhibitor.  This would 
allow us to observe differences in the ability of the HSCs to stop progression into 
anaphase while the checkpoint is activated. 
 
To determine if aged Mad2+/- mice do in fact develop a MPD, further analysis can 
be performed on additional unstained slides prepared from the previously 
collected samples discussed in the Results section to determine which 
hematopoietic lineage is leading to clonal proliferation observed in the various 
organs.  The disorders included in the classification of MPD [PV, CIMF, ET, CML, 
and CMML (Talarico 1998)], exhibit various changes in the hematopoietic 
compartment.  Determining the composition of the infiltrating hematopoietic cells 
could point us toward one specific disorder, and potentially help us identify other 
diagnostic criteria to look for in later studies.  Also, a study examining age and 
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sex matched Mad2+/+ and Mad2+/- mice could be set up; at various time points, 
the peripheral blood could be examined for changes in the hematocrit, platelet 
count, white blood cell count, and red blood cell morphology (Linker Charles A).  
If abnormalities exist in these areas, the mice would be sacrificed and the bone 
marrow, spleen, liver and other organs could be examined for further indications 
of MPD. 
 
In our studies examining the effect of Mad2 haploinsufficiency on recovery of BM 
HPC from in vivo cytotoxic effects, we used two non-cycle specific agents, but 
only one cell-cycle specific agent, Ara-C.  Since we observed that Mad2+/- HPC, 
but not Mad2+/+ HPC, are protected from the cytotoxic effects of Ara-C, we 
wanted to determine if these observations were unique to treatment with Ara-C, 
or if we would obtain similar results with another cycle specific agent.  Therefore, 
we would like to examine the recovery of Mad2+/+ and Mad2+/- HPC after 
treatment with 5-Fluorouracil (5-FU).  5-FU inhibits the activity of thymidylate 
synthetase (Peters, et al. 2002), which affects pyrimidine synthesis and leads to 
depletion of intracellular TTP pools (Elstein, et al. 1997).  We will inject Mad2+/+ 
and Mad2+/- mice with 5-FU (150 mg/kg, intravenous (i.v.)) on day zero of the 
experiment.  We will analyze the mice at days 5, 7, and 9 after treatment, and 
both control Mad2+/+ and Mad2+/- mice will be assessed at day zero without any 
treatment.  For analysis, BM and spleen will be aseptically harvested from the 
treated mice at the various time points stated above, and colony assays will be  
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set up as previously described.  If our results with Ara-C are common to cycle 
specific inhibitors, then we would expect to see a protective effect in the Mad2+/- 
HPC after 5-FU treatment. 
 
APE1 has been shown to regulate cell cycle status in EB-derived hematopoietic 
progenitors, and to positively regulate the G1/S transition in EB cells (Zou, et al. 
2007).  We have found that inhibition of the redox function of APE1 in Mad2+/- 
HPC is less effective when compared to Mad2+/+ HPC, possibly suggesting that 
Mad2+/- HPC are less sensitive the effects of E3330 because they already exhibit 
cell cycle defects.  It is possible that the reduced sensitivity of Mad2+/- HPC to 
E3330 is due to the fact the E3330 blocks signaling in the cell cycle that is 
already defective in the Mad2+/- HPC.  If this were true, this could explain why 
E3330 is more effective in the Mad2+/+ HPC.  Therefore we need to determine 
the role that APE1 plays in cell cycle regulation.  We will examine both Mad2+/+ 
and Mad2+/- HPC after treatment with E3330 or vehicle control for changes in 
important cell cycle proteins, such as cyclins, securin, CDKs, and active APC/C, 
to determine how both APE1 redox function and Mad2 haploinsufficiency affect 
cell cycle transitions. 
 
Our data demonstrating that the colony formation of Mad2+/+ HPC is significantly 
inhibited by E3330 suggests that the redox function of APE1 is important in 
normal adult hematopoiesis, particularly for HPC growing under lower oxygen 
tension.  This also suggests that transcription factors that are normally 
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upregulated under lowered oxygen conditions may be important for colony 
formation and growth.  The growth inhibitory effects of E3330 are accentuated by 
hypoxia in pancreatic cancer cells (Zou and Maitra 2008), also suggesting an 
enhanced requirement for Ape1/Ref-1 redox function in hypoxia.  We will culture 
wild-type HPC under both 5% and 20% O2 tension, and in the presence and 
absence of E3330, to determine how oxygen tension effects the activation of 
transcription factors, such as Egr-1, HIF-1α, and AP-1, which are known to be 
activated by the redox function of APE1. 
 
We will also examine these transcription factors in Mad2+/- HPC under the same 
conditions as Mad2+/+ HPC.  Mad2+/- HPCs are not only less sensitive to 
inhibition by E3330, but also are not responsive to changes in oxygen tension.  
To examine if reactive oxygen species (ROS) plays a role in the lack of response 
to changes in oxygen tension, we will compare Mad2+/- and Mad2+/+ HPC growth 
in the presence and absence of the ROS scavenger NAC (N-acetyl-L-cysteine) in 
5% and 20% O2 tension to see if this will have an effect on colony number.  
Other potential factors that could lead to decreases in Mad2+/- HPC sensitivity to 
E3330 could be changes in APE1 levels, the binding affinity of E3330 to APE1, 
and transcription factor activation mediated by the redox function of APE1.  It is 
also important to consider that possibility that Mad2+/- HPC might exhibit a multi-
drug resistance (MDR) in response to E3330.  MDR is a condition in which cells 
or organisms are able to resist drugs or chemicals targeted at eradicating them.  
MDR to a particular drug can be brought about by many different mechanisms, 
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including enzymatic deactivation, altered metabolic pathways, decreased cell 
permeability, and increased efflux.  A study examining P-glycoprotein (Pgp) and 
multidrug resistance protein 1 (MRP1) in mouse HSC and HPC found that MRP1 
activity was present among different subpopulations of precursor cells (Kyle-
Cezar, et al. 2007).  Pgp and MRP1 are members of the ATP-binding cassette 
(ABC) family of transporter proteins.  Both molecules are membrane-associated, 
energy-dependent efflux pumps with different substrate selectivity, and they may 
play a role in the activation, differentiation and function of hematopoietic cells.  
Since MRP1 is present in both HSC and HPC from mice, this protein needs to be 
examined in Mad2+/- hematopoietic populations to determine if it is more active, 
which could lead to decreased sensitivity to E3330. 
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